Contiguity preserving transposition
Patent Information
- Application Number
- JP2024124506
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2015-10-16
- Filing Date
- 2024-07-31
- Publication Date
- 2024-11-21
- Estimated Expiration
- 2035-10-16
AI Technical Summary
Current nucleic acid sequencing methods face challenges in efficiently handling large volumes of data and maintaining the continuity of nucleic acid sequences, particularly in detecting specific sequences for applications such as cancer diagnosis and genetic analysis, where traditional methods struggle with fragmentation and loss of continuity during processing.
A method involving the use of transposome complexes to fragment and tag nucleic acids with barcode sequences, maintaining continuity by immobilizing fragments on solid supports with unique barcodes, allowing for efficient sequencing and analysis of nucleic acid sequences.
This approach enables the preservation of nucleic acid continuity, facilitating accurate sequencing and analysis of genetic information, including methylation status and phasing information, with improved efficiency and reduced need for additional purification steps.
Abstract
Description
[Technical field]
[0001] Related Applications This application is filed on Oct. 17, 2014, which is incorporated herein by reference in its entirety. No. 62 / 065,544, filed May 5, 2015, and U.S. Provisional Patent Application No. Priority is claimed from Application No. 62 / 157,396.
[0002] Embodiments of the present invention relate to the sequencing of nucleic acids. Embodiments of the methods and compositions include preparing nucleic acid templates and obtaining sequence data from the nucleic acid templates. Regarding. [Background technology]
[0003] The detection of specific nucleic acid sequences present in a biological sample can be used to, for example, identify and classify microorganisms, identify infections, and diagnosis of cancer; detection and characterization of genetic abnormalities; identification of genetic alterations associated with cancer; It is used as a method to study genetic susceptibility and to measure response to various types of treatment. A common technique for detecting specific nucleic acid sequences in biological samples is nucleic acid sequencing. It is gu.
[0004] Nucleic acid sequencing methods include the chemical degradation method used by Maxam and Gilbert, and There have been significant developments since Sanger's chain elongation method. Today, the parallel processing of nucleic acids can all be done in one Several sequencing methods are available that allow for multiple sequencing runs. Therefore, the information generated from a single sequencing run is enormous. It is possible that... Summary of the Invention [Means for solving the problem]
[0005] In one embodiment, the present disclosure provides a method for the identification of barcoded DNA fragments of a target nucleic acid. A method for preparing a library is described, the method comprising: and contacting each transposome complex with a transposome complex comprising: The transposon contains a transferred strand and a non-transferred strand. At least one transposon in the transpososome complex hybridizes to a complementary capture sequence. The target nucleic acid is fragmented into multiple fragments by fragmenting the target nucleic acid. This allows the fragmentation of the target nucleic acid while maintaining its contiguity. Insert multiple transferred strands at the 5' end of at least one strand. Insert multiple fragments of the target nucleic acid. The antibody is contacted with a plurality of solid supports, each of which has a plurality of immobilized oligonucleotides. Each oligonucleotide comprises a complementary capture sequence and a first barcode sequence. a first barcode sequence from each solid support in the plurality of solid supports, The barcode sequence information is different from the first barcode sequence from other solid supports in the carrier. to a fragment of the target nucleic acid, thereby forming at least two fragments of the same target nucleic acid. At least one strand is connected to the first barcode so that all fragments receive the same barcode information. An immobilized library of double-stranded fragments is generated, 5'-tagged with coding sequences.
[0006] In one aspect, the present specification relates to a method for determining contiguous information of a target nucleic acid sequence. The method includes contacting a target nucleic acid with a plurality of transposome complexes. Each transposome complex contains a transposon and a transposase. The transposon contains a transferred strand and a non-transferred strand, and the transposon of the transposome complex At least one of the zones is an adaptor capable of hybridizing to a complementary capture sequence. The target nucleic acid is fragmented into a plurality of fragments, and the continuity of the target nucleic acid is The transfer strands are inserted into multiple fragments while maintaining the target nucleic acid. The agent is contacted with a plurality of solid supports, each of the plurality of solid supports carrying a plurality of immobilized oligonucleotides. each oligonucleotide having a complementary capture sequence and a first barcode sequence wherein the first barcode sequence from each solid support in the plurality of solid supports is The barcode sequence information is different from the first barcode sequence from other solid supports in the support. The barcode information is then read out so that at least two fragments of the same target nucleic acid receive identical barcode information. The sequence and barcode of the target nucleic acid fragment are transferred to the target nucleic acid fragment. Determine the sequence. The sequence information of the target nucleic acid is determined by identifying the barcode sequence. In some embodiments, the transposase of the transposome complex is After the transposition, the adapter sequence of the transposon is removed. In some embodiments, the transposase is hybridized to a complementary capture sequence. In some embodiments, the transposase is removed by SDS treatment. It is removed by treatment with proteinases.
[0007] In one aspect, the present disclosure provides phasing information and methylation status of a target nucleic acid sequence. The present invention describes a method for simultaneously measuring the number of transposons that can be detected by integrating a target nucleic acid into multiple transposons. and contacting each transposome complex with a transposon. The transposon comprises a transferring strand and a non-transferring strand, and the transposon comprises a transposase. At least one of the transposons in the sposome complex hybridizes to a complementary capture sequence. The target nucleic acid is fragmented into multiple fragments. and inserting multiple transfer strands into a target nucleic acid fragment while maintaining the continuity of the target nucleic acid. A plurality of fragments of the target nucleic acid are contacted with a plurality of solid supports, and a plurality of solid supports are Each of the oligonucleotides comprises a plurality of immobilized oligonucleotides, each of which is a complementary capture a first barcode sequence from each solid support in the plurality of solid supports, The barcode sequence is a first barcode sequence from another solid support in the plurality of solid supports. The barcode sequence information is different. At least two fragments of the same target nucleic acid are identical. The barcode information is transferred to the target nucleic acid fragment. The target nucleic acid fragment containing the barcode is subjected to bisulfite treatment, thereby forming a barcode-containing bisulfite fragment. Produce bisulfite-treated target nucleic acid fragments. The sequence of the target nucleic acid and the barcode sequence are determined. The determination is made by distinguishing
[0008] In one embodiment, the present disclosure provides an immobilized library of tagged DNA fragments. The method for preparing a transposome complex immobilized thereon is described. providing a plurality of solid supports having transposome complexes, Transposome monomer units of the same transposome complex bind to each other and the transpososome monomer unit comprises a transposase bound to a first polynucleotide, The first polynucleotide comprises (i) a 3' portion including a transposon end sequence, and (ii ) a first adapter that includes a first barcode. The first polynucleotide is fragmented by the sposome complex and the 3' transposon of the first polynucleotide is inserted into the under conditions in which the terminal sequence of the nucleotide is transferred to the 5' end of at least one strand of the fragment. The solid support is then applied to the solid support, whereby at least one strand is 5' tagged with a first barcode. An immobilized library of tagged double-stranded fragments is generated.
[0009] In one embodiment, the present disclosure provides a sequencing method for determining the methylation status of a target nucleic acid. A method for preparing a sequencing library is described, which comprises: The first common adapter sequence is The adapter sequence is incorporated into the 5' end of the target nucleic acid fragment, and the adapter sequence is It comprises a binding sequence and an affinity moiety, the affinity moiety being present in one member of the binding pair. The target nucleic acid fragments are denatured. The target nucleic acid fragments are immobilized on a solid support. The solid support comprises the other member of the binding pair, and immobilization of the target nucleic acid is effected by binding of the binding pair. The immobilized target nucleic acid fragment is subjected to bisulfite treatment. A second common adapter sequence was then incorporated into the bisulfite-treated immobilized target nucleic acid fragment. The bisulfite-treated substrate immobilized on a solid support contains a second primer binding site. and amplifying the immobilized target nucleic acid fragment, thereby determining the methylation state of the target nucleic acid. A sequencing library is prepared for this purpose.
[0010] In one embodiment, the present disclosure provides a sequencing method for determining the methylation status of a target nucleic acid. A method for preparing a sensing library is described, which comprises immobilizing The method includes providing a plurality of solid supports containing immobilized transposome complexes. The sposome complex comprises a transposon and a transposase, the transposon being The transferred strand comprises a transferred strand and a non-transferred strand. The transferred strand comprises (i) a 3' end that contains a transposase recognition sequence; and (ii) a first portion comprising a first adapter sequence and a first member of a binding pair. ' to the first moiety. The first member of the binding pair is attached to a solid support. The transposon binds to a second member of the binding pair on the solid support, thereby attaching the transposon to the solid support. The first adaptor also contains a first primer binding sequence. The non-transferred strand is (i) a first portion at the 5' end that contains a transposase recognition sequence and (ii) a second portion at the 3' end that contains a transposase recognition sequence. 3' to the first portion, which contains a second adapter sequence with the terminal nucleotide blocked. The second adaptor also comprises a second primer binding sequence. The target nucleic acid is contacted with a plurality of solid supports containing immobilized transposome complexes. The target nucleic acid is fragmented into a plurality of fragments, and the plurality of transferred strands are separated into at least one of the fragments. The 5' end of each strand is inserted into the 5' end of the target nucleic acid fragment, thereby immobilizing the target nucleic acid fragment on the solid support. The 3' end of the fragmented target nucleic acid is extended with DNA polymerase. The non-transferred strand is ligated to the 3' end of the fragmented target nucleic acid. The target nucleic acid fragment is subjected to bisulfite treatment. Fixation damaged during bisulfite treatment The 3' end of the immobilized target nucleic acid fragment is fused to a homopolysaccharide. The second adaptor is extended with DNA polymerase to include a repeat tail. Sequences were introduced into the 3' ends of immobilized target nucleic acid fragments that were damaged during bisulfite treatment. The bisulfite-treated target nucleic acid fragments immobilized on the solid support are then introduced into the first and second A second primer is used to amplify the nucleic acid, thereby determining the methylation state of the target nucleic acid. A sequencing library is prepared.
[0011] In one embodiment, the present disclosure provides a sequencing method for determining the methylation status of a target nucleic acid. A method for preparing a sequencing library is described, the method comprising: The method includes contacting a transposome complex with a transposome. Transposons include a transferred strand and a non-transferred strand. The transferred strand comprises (i) a first portion at the 3' end that contains a transposase recognition sequence and (ii) A first adapter sequence and a first member of a binding pair are located 5' to the first portion. and a second portion that binds to the first member of the binding pair, the first member of the binding pair being capable of binding to the second member of the binding pair. The non-transferred strand comprises (i) a first portion at the 5' end that contains a transposase recognition sequence and (i i) a 3' adapter sequence containing a second adapter sequence in which the terminal nucleotide at the 3' end is blocked; the second adaptor comprises a second portion located between the first portion and the second primer bond The target nucleic acid is fragmented into multiple fragments, and multiple transferred strands are fragmented. at the 5' end of at least one strand of the target nucleic acid fragment, thereby The target nucleic acid fragment containing the transposon end is immobilized on a solid support. and contacting the solid support with a second member of the binding pair, Binding to the second member of the pair immobilizes the target nucleic acid to the solid support. The 3' end of the transferred target nucleic acid is extended with DNA polymerase. The immobilized target nucleic acid fragment is ligated to the 3' end of the fragmented target nucleic acid. The immobilized target nucleic acid fragments damaged during bisulfite treatment are then subjected to bisulfite treatment. The 3' end of the immobilized target nucleic acid fragment is then modified so that the 3' end of the immobilized target nucleic acid fragment contains a homopolymeric tail. The second adaptor sequence is then extended using DNA polymerase as shown in FIG. The 3' end of the immobilized target nucleic acid fragment is introduced into the solid support, which is damaged during processing. The immobilized bisulfite-treated target nucleic acid fragments are subjected to amplification using first and second primers. and amplifying the target nucleic acid, thereby providing a sequencing library for determining the methylation status of the target nucleic acid. Create a library.
[0012] In some embodiments, the terminal nucleotide at the 3' end of the second adaptor is Selected from the group consisting of deoxynucleotides, phosphate groups, thiophosphate groups, and azide groups. Blocking by one member.
[0013] In some embodiments, the affinity moiety can be a member of a binding pair. In some cases, the modified nucleic acid comprises a first member of a binding pair. In some cases, the capture probe may comprise a second member of the binding pair. In this case, the capture probe may be immobilized on a solid surface and the modified nucleic acid may be attached to a binding peptide. The capture probe may comprise a first member of the binding pair, and the capture probe may comprise a second member of the binding pair. In such cases, binding of the first and second members of the binding pair may include The modified target nucleic acid is immobilized on a solid surface by binding pairs such as, but not limited to, However, biotin-avidin, biotin-streptavidin, and biotin-neutral are not used. Ravidin, Ligand-receptor, Hormone-receptor, Lectin-glycoprotein, Oligonucleotide nucleotide-complementary oligonucleotides, and antigen-antibody.
[0014] In some embodiments, the first common adapter sequence is d) Incorporation into the 5'-end fragment of the target nucleic acid by transposition. In some embodiments The first common adaptor sequence is ligated to the 5' end fragment of the target nucleic acid. In some embodiments, the second common adapter sequence is incorporated into the bisulfite The step of incorporating into the treated immobilized target nucleic acid fragments comprises: (i) incorporating into the immobilized target nucleic acid fragments The 3' end of the fragment was extended with terminal transferase to form a homopolymer tail. (ii) an oligonucleotide comprising a single-stranded homopolymer portion; a step of hybridizing a double-stranded portion comprising two common adapter sequences, the single-stranded homopolymer portion is complementary to the homopolymer tail; and (iii) ) ligating a second common adapter sequence to the immobilized target nucleic acid fragment, thereby , incorporating a second common adaptor sequence into the bisulfite-treated immobilized target nucleic acid fragments. Includes steps.
[0015] In some embodiments, the target nucleic acid is derived from a single cell. In some embodiments, the target nucleic acid is derived from a single organelle. The target nucleic acid is genomic DNA. In some embodiments, the target nucleic acid is a nucleic acid that is a nucleic acid that is a nucleic acid fragment of another nucleic acid. In some embodiments, the target nucleic acid is crosslinked with formalin-fixed paraffin-embedded (FFPE:formarin fixed paraffin embedded) In some embodiments, the target nucleic acid is crosslinked to a protein. In some embodiments, the target nucleic acid is crosslinked to DNA. In some embodiments, the target nucleic acid is histone-protected DNA. Histones are removed from the target nucleic acid. In some embodiments, the target nucleic acid is an acellular marker. In some embodiments, the cell-free tumor DNA is obtained from placental fluid. In some embodiments, the cell-free tumor DNA is obtained from plasma. In the method, plasma is collected from whole blood using a membrane separator having a collection zone for plasma. In some embodiments, the collection zone for plasma comprises a transposon immobilized on a solid support. In some embodiments, the target nucleic acid is a cDNA. In some embodiments, the solid support is a bead. The plurality of solid supports is a plurality of beads, the plurality of beads being of various sizes.
[0016] In some embodiments, a single barcode sequence is provided for each of the multiple barcodes on each individual solid support. In some embodiments, different barcodes are present on the immobilized oligonucleotides. The sequence is present on multiple immobilized oligonucleotides on each individual solid support. In some embodiments, the transfer of barcode sequence information to the target nucleic acid fragments is performed by ligation. In some embodiments, barcodes are placed on target nucleic acid fragments. The transfer of sequence information is by polymerase extension. In some embodiments, the target nucleic acid fragment is The transfer of barcode sequence information to the fragment involves both ligation and polymerase extension. In some embodiments, the polymerase extension is performed using ligated immobilized oligonucleotides. The 3' end of the unligated transposon strand was then ligated to a DNA fragment using the oligonucleotide as a template. In some embodiments, the adapter sequence is extended with a ribozyme. At least some further comprise a second barcode sequence.
[0017] In some embodiments, the transposome complex is a multimer, with each monomer unit The adapter sequence of the transposon at position 1 is expressed by other monomer units of the same transposome complex. In some embodiments, the adapter sequence is different from the first primer binding sequence. In some embodiments, the first primer binding site further comprises a capture sequence or has no sequence homology to the complement of the capture sequence. The immobilized oligonucleotide on the solid support further comprises a second primer binding sequence.
[0018] In some embodiments, the transposome complex is multimeric and The transpososome monomer units bind to each other within the same transpososome complex. In terms of morphology, the transposase of the transpososome monomer unit is the same as that of the The transposase of another transpososome monomer unit of the chromosome complex is bound to the transposase of another transpososome monomer unit of the chromosome complex. In an embodiment, the transposons of the transposome monomer units are the same transposons. The transposon of another transpososome monomer unit of the chromosome complex binds to the transposon. In an embodiment, the transposases of the transposome monomer units are The transposase is covalently linked to another transpososome monomer unit of the transpososome complex. In some embodiments, the transposase of one monomer unit is Disulfide transposase from another transpososome monomer unit of the transposome complex In some embodiments, the transposome monomer units are linked by a tRNA bond. The transposon is a transposon of another transpososome monomer unit of the same transposome complex. It is covalently bound to the transposon.
[0019] In some embodiments, the contiguous information of the target nucleic acid sequence represents haplotype information. In some embodiments, the contiguous information of the target nucleic acid sequence indicates genomic variations. In some embodiments, the genomic alterations include deletions, translocations, , interchromosomal gene fusions, duplications, and paralogs. In an embodiment, the oligonucleotide immobilized on the solid support has a partially double-stranded region and In some embodiments, the oligonucleotide comprises a partially single-stranded region. The single-stranded region includes a second barcode sequence and a second primer binding sequence. In an embodiment, the target nucleic acid fragment containing the barcode is In some embodiments, the target nucleic acid fragment is amplified prior to sequencing. In some embodiments, the fragments are sequenced in a single reaction compartment. A third barcode sequence is introduced into the target nucleic acid fragment during amplification.
[0020] In some embodiments, the method further comprises: a pool of target nucleic acid fragments comprising barcodes from a first set of reaction compartments; aggregating said pool of target nucleic acid fragments comprising barcodes into a plurality of second and redistributing the target nucleic acid fragments into a second set of reaction compartments. The third barcode is then linked to the target nucleic acid fragment by pre-sequencing amplification in the reaction compartment. The method may further include the step of introducing the material into a fragment.
[0021] In some embodiments, the method further comprises contacting the target nucleic acid with a transposome complex. In some implementations, the method may further include the step of prefragmenting the data before the data is fragmented. In the present embodiment, the prefragmentation of the target nucleic acid is carried out by a method selected from the group consisting of sonication and restriction digestion. The method is selected from the following: [Brief description of the drawings]
[0022] [Figure 1] 1 is a flow chart showing an example of a method for binding transposomes to a bead surface. [Diagram 2] 2 is a pictorial diagram illustrating steps of the method of FIG. 1; FIG. [Diagram 3] FIG. 1 is a schematic diagram showing an example of a tagmentation process on a bead surface. [Figure 4] FIG. 4 is a data table showing an example of DNA yield in terms of cluster number from the bead-based tagmentation process of FIG. 3. [Diagram 5]FIG. 4 is a data table showing another example of the reproducibility of the bead-based tagmentation process of FIG. 3 in terms of uniform size. [Figure 6] 6A and 6B show insert size plots for pool 1 and pool 2 of the indexed samples of FIG. 5, respectively. [Figure 7] 6 is a bar graph showing the reproducibility of the total number of reads and the percentage of aligned reads for the experiments described in FIG. 5. [Figure 8] 8A, 8B, and 8C show plots of insert size for a control library, a plot of insert size for a bead-based tagmented library, and a summary data table, respectively, in an exome enrichment assay. [Figure 9] 9A, 9B, and 9C show bar graphs of dups PF fraction, selected bases fraction, and PCT usable bases on target in the exome enrichment assay, respectively. [Figure 10] 1 is a flow chart showing an example of a method for forming a transposome complex on a bead surface. [Figure 11] 11 is a pictorial diagram illustrating the method steps of FIG. 10. [Figure 12] 11 is a pictorial diagram illustrating the method steps of FIG. 10. [Figure 13] 11 is a pictorial diagram illustrating the method steps of FIG. 10. [Figure 14] FIG. 14 is a schematic diagram of the tagmentation process using transposome-coated beads shown in FIG. [Figure 15] FIG. 1 shows an exemplary scheme for transposome formation on a solid support. [Figure 16] FIG. 1 shows an exemplary scheme for generating contiguously linked libraries with unique indexes. [Figure 17] FIG. 1 shows an exemplary scheme for creating a concatenated library with a unique index. [Figure 18]FIG. 13 depicts capture of a single CPT-DNA on a single clonal indexed bead, where the CPT-DNA is wrapped around the bead. [Figure 19] FIG. 13 depicts capture of a single CPT-DNA on a single clonal indexed bead, where the CPT-DNA is wrapped around the bead. [Figure 20] FIG. 1 shows an exemplary scheme for attaching Y-adapters immobilized on a solid surface to target DNA by ligation and gap filling. [Figure 21] FIG. 1 shows an exemplary scheme for generating the Y-adapter during ligation of CPT-DNA with an immobilized oligonucleotide on a solid support. [Figure 22] FIG. 13 depicts an agarose gel electrophoresis showing removal of free transposomes from a ligated library by size exclusion chromatography. [Diagram 23] FIG. 1 shows an exemplary scheme for generating a shotgun sequence library of specific DNA fragments. [Figure 24] FIG. 1 shows an exemplary scheme for assembling sequence information from a clone-indexed sequencing library. [Diagram 25] FIG. 1 shows the results of optimizing capture probe density on beads. [Figure 26] FIG. 1 shows the results of testing the feasibility of preparing indexed sequencing libraries of CPT-DNA on beads by intramolecular hybridization. [Figure 27] FIG. 1 shows the results of testing the feasibility of clone indexing. [Figure 28] 1 is a graph showing the frequency of sequencing reads aligned adjacently to a template nucleic acid after tagmentation for a particular intra-island and intra-island distance. [Figure 29] 29A and 29B show an exemplary approach to derive continuity information on a solid support. [Diagram 30] FIG. 1 shows a schematic diagram of indexed clonal bead transposition in a single reaction vessel (one-pot) and transposition results. [Diagram 31] FIG. 1 shows a schematic diagram of indexed clonal bead transposition in a single reaction vessel (one-pot) and transposition results. [Diagram 32] FIG. 1 is a schematic diagram showing the generation of clonal transposomes on beads using 5′ or 3′ biotinylated oligonucleotides. [Diagram 33] FIG. 1 shows library size relative to transposomes on beads. [Diagram 34] FIG. 1 shows the effect of transposome surface density on insert size. [Diagram 35] FIG. 1 shows the effect of input DNA on size distribution. [Diagram 36] FIG. 1 shows islet size and distribution using bead-based and solution-based tagmentation reactions. [Figure 37] FIG. 1 shows clonal indexing of several individual DNA molecules, each of which received a unique index. [Figure 38] 1 is a schematic diagram of an apparatus for separating plasma from whole blood. [Figure 39] 1 is a schematic diagram showing an apparatus for separating plasma and the subsequent use of the separated plasma. [Diagram 40] 1 is a schematic diagram showing an apparatus for separating plasma and the subsequent use of the separated plasma. [Diagram 41] FIG. 1 shows an exemplary scheme for targeted phasing by enriching specific regions of the genome. [Diagram 42] FIG. 1 shows an exemplary scheme for exome phasing using inter-exonic SNPs. [Diagram 43] FIG. 1 shows an exemplary scheme for simultaneous detection of phasing and methylation. [Diagram 44] FIG. 1 shows another exemplary scheme for simultaneous detection of phasing and methylation. [Diagram 45] FIG. 1 shows an exemplary scheme for generating libraries of different sizes using clonal indexed beads of different sizes in a single assay. [Diagram 46] FIG. 1 shows an exemplary scheme for determining genetic variation in libraries of different length scales. [Figure 47A] FIG. 1 shows the results of detection of a 60 kb heterozygous deletion in chromosome 1. [Figure 47B] FIG. 1 shows the results of detection of a 60 kb heterozygous deletion in chromosome 1. [Figure 48] FIG. 1 shows the results of gene fusion detection using the method of the present application. [Figure 49] FIG. 1 shows the results of gene deletion detection using the method of the present application. [Figure 50] FIG. 13 shows ME sequences before and after bisulfite conversion. [Figure 51] FIG. 1 shows the results of optimization of bisulfite conversion efficiency. [Figure 52] FIG. 1 shows the results after bisulfite conversion as an IVC plot (intensity vs. cycles per base). [Figure 53] FIG. 13 shows an image of an agarose gel electrophoresis of the indexed combined library after PCR after BSC. [Figure 54] FIG. 13 shows a bioanalyzer trace of a pre-enriched whole-genome indexed combined CPT-seq library without size selection. [Figure 55] FIG. 1 shows an agarose gel analysis of the enriched library. [Figure 56] FIG. 1 shows the results of applying targeted haplotyping to the HLA regions of chromosomes. [Figure 57] FIG. 1 illustrates some possible mechanisms of ME swapping. [Figure 58] FIG. 1 illustrates some possible mechanisms of ME swapping. [Figure 59]FIG. 1 shows a portion of Tn5 transposase with exemplary amino acid residues Asp468, Tyr407, Asp461, Lys459, Ser458, Gly462, Ala466, Met470 that can be substituted with Cys. [Figure 60] FIG. 1 shows a portion of Tn5 transposase with amino acid substitutions S458C, K459C, and A466C that allow cysteine residues to form disulfide bonds between two monomeric units. [Figure 61] FIG. 1 shows an exemplary scheme for the preparation and use of dimeric transposase (dTnp) nanoparticle (NP) bioconjugates (dTnp-NP) using amine-coated nanoparticles. [Figure 62] FIG. 1 shows an exemplary scheme for conjugation of a transposome dimer to an amine-coated solid support. [Figure 63] FIG. 1 shows the Mu transposome complex with transposon ends bound. [Figure 64] FIG. 13: Schematic representation of indexed combined reads for pseudogene assembly / phasing and the advantages of pseudogene mutation discrimination using shorter fragments. [Figure 65] FIG. 1 shows plots of index exchange from four separate experiments, shown as the percentage of index swapped. [Figure 66] FIG. 1 shows Agilent BioAnalyzer analysis of fragment sizes of Ts-Tn5 titrations. [Figure 67] FIG. 1 shows an exemplary scheme for improving the DNA yield of the Epi-CPTSeq protocol using an enzymatic method to restore damaged library elements after bisulfite treatment. [Figure 68] 68A-68C show several exemplary schemes for improving the DNA yield of the Epi-CPTSeq protocol using an enzymatic method to restore damaged library elements after bisulfite treatment. [Figure 69]FIG. 1 shows an exemplary scheme for template rescue using random primer extension. [Figure 70] Figure 1 shows fragmentation of DNA libraries during sodium bisulfite conversion. The left panel shows fragmentation during bisulfite conversion of a portion of DNA tagmented onto magnetic beads. The right panel shows bioanalyzer traces of CPT-seq and Epi-CPT-seq (Me-CPT-seq) libraries. [Figure 71] FIG. 1 shows an exemplary scheme and results of a TdT-mediated ssDNA ligation reaction. [Figure 72] Figure 1 shows the scheme and results of TdT-mediated recovery of sodium bisulfite-converted beads bound to a library. The left panel shows the operation flow for rescue of a damaged bisulfite-converted DNA library using a TdT-mediated ligation reaction. The results of the DNA library rescue experiment are shown in the right panel. [Figure 73] FIG. 1 shows the results of a methyl-CPT-seq assay. [Figure 74] FIG. 1 shows an exemplary scheme for bead-based bisulfite conversion of DNA. [Figure 75] 75A and 75B show the results of optimizing bisulfite conversion efficiency. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0023] Embodiments of the present invention relate to the sequencing of nucleic acids. Embodiments of the methods and compositions include preparing nucleic acid templates and obtaining sequence data from the nucleic acid templates. Regarding.
[0024] In one embodiment, the present invention provides a method for the preparation of a tagmented (fragmented and tagged) target. A method for tagmenting target nucleic acids on a solid support to construct a nucleic acid library. In one embodiment, the solid support is a bead. In this case, the target nucleic acid is DNA.
[0025] In one embodiment, the present invention provides a solid-state imaging system capable of deriving sequence information of a target nucleic acid. The present invention relates to supports, methods and compositions for transposase-based methods. In some embodiments, the compositions and methods can derive assembly / phasing information. .
[0026] In one embodiment, the present invention relates to a method for capturing the linked transposition target nucleic acid on a solid support. The present invention relates to methods and compositions for deriving continuity information.
[0027] In one embodiment, the methods and compositions disclosed herein relate to the analysis of genomic variations. Exemplary genomic alterations include, but are not limited to, deletions, interchromosomal rearrangements, duplications, In some embodiments, the present invention includes a gene that is a chromosome-specific fusion, a paralog, or an interchromosomal gene fusion. The disclosed methods and compositions relate to determining phasing information of genomic variations.
[0028] In one embodiment, the methods and compositions disclosed herein provide for the detection of specific regions of a target nucleic acid. In one embodiment, the target nucleic acid is DNA. In some embodiments, the target nucleic acid is genomic DNA. The nucleic acid is RNA. In some embodiments, the RNA is mRNA. In some embodiments, the target nucleic acid is a complementary DNA (cDNA). In some embodiments, the target nucleic acid is derived from a single cell. In some embodiments, the target nucleic acid is derived from a circulating tumor cell. In embodiments, the target nucleic acid is cell-free DNA. In some embodiments, the target nucleic acid is acellular tumor DNA. In some embodiments, the target nuclei are derived from phosphorus-fixed paraffin-embedded tissue samples. In some embodiments, the target nucleic acid is crosslinked to a protein. In some embodiments, the target nucleic acid is bridged to the nucleic acid. In some embodiments, the target nucleic acid is histone-protected DNA. Histone-protected DNA was precipitated from cell lysates using antibodies against histones. and removing histones.
[0029] In some embodiments, the indexed library is a clone-indexed library. In some embodiments, the tagmented beads are used to generate the target nucleic acid. The target nucleic acid is cloned and indexed while the transposase remains bound to the target DNA. In some embodiments, specific capture proteins can be used to capture the proteins. The probe is used to capture a specific region of interest in the target nucleic acid. The regions are washed at various stringencies, optionally amplified, and then sequenced. In some embodiments, the capture probe may be biotinylated. The biotinylated capture probe hybridizes to a specific region of the indexed target nucleic acid. The fused complexes can be separated using streptavidin beads. An exemplary scheme for filtering is shown in FIG.
[0030] In some embodiments, the compositions and methods disclosed herein provide for the analysis of the phenotype of the exome. In some embodiments, the exons, promoters, Markers, such as heterozygous SNPs between exon regions, can be enriched. This may be useful for exon phasing when the distance between exons is large. The phasing of the exome over time is shown in Figure 42. The combined cross-referenced reads simultaneously span heterozygous SNPs in adjacent exons (coverage Therefore, phasing two or more exons is not possible. The compositions and methods disclosed herein also provide for the detection of inter-exon heterozygous SNPs. enrich for exon 1 and phase SNP 2 to exon 2, for example Therefore, through the use of SNP1, exon 1 and exon 2 are It can be faded.
[0031] In one embodiment, the compositions and methods disclosed herein provide for fading and simultaneous It can be used to detect methylation. Methylation detection by conversion is difficult because the BSC reaction is harsh on DNA ( It is harsh and fragments DNA, which reduces continuity / phasing. This is difficult because it removes information. Also, the method disclosed in this application is different from the conventional BSC approach. In contrast to the method required for the synthesis of 1,2-dichlorophenyl ether, no further purification steps are required, thereby increasing the yield. There is a further advantage to improving
[0032] In one embodiment, the compositions and methods disclosed herein are used to generate laminae of different sizes. In some embodiments, the library can be prepared in one assay. Different sizes of clone-indexed beads were used to separate libraries of different sizes. FIG. 1 illustrates a method 100 for attaching a transposase to a bead surface. 1 shows a flow chart of an example of a method for the transposase synthesis of a transposon oligonucleotide. The beads are then coated with the enzyme, transposase, and any chemicals that may be added to the solid phase. In one example, the transposome may be attached to a biotin-streptavidin complex. The method 100 can include, but is not limited to, , including the following steps.
[0033] In one embodiment, the transposon comprises a sequencing primer binding site. Exemplary sequences of sequence binding sites include, but are not limited to, AATGATACGGGCGACCACCGAGATCTACAC (P5 sequence) and C AAGCAGAAGACGGCATACGAGAT (P7 sequence). In this embodiment, the transposon may be biotinylated.
[0034] In step 110 of FIG. 1, the P5 and P7 biotinylated transposons are generated. Transposons also contain one or more index sequences (unique identifiers). Exemplary index sequences include, but are not limited to, TAGATC GC, CTCTCTAT, TATCCTCT, AGAGTAGA, GTAAGGAG, A CTGCATA, AAGGAGTA, and CTAAGCCT. Another example is P5 Only the transposon or only the P7 transposon is biotinylated. Transposons can contain only mosaic end (ME) sequences or In addition to the sequence, it contains an additional sequence that is not the P5 and P7 sequences. In this example, the P5 and P7 sequences is added in the subsequent PCR amplification step.
[0035] In step 115 of FIG. 1, the transposome is assembled. The transposomes are a mixture of P5 and P7 transposomes. The mixture of amposomes is described in more detail in connection with FIGS.
[0036] In step 120 of FIG. 1, the P5 / P7 transposome mixture is applied to the bead surface. In this example, the beads are streptavidin-coated beads, and the transposon is The serosomes are bound to the bead surface via a biotin-streptavidin binding complex. The beads may be of various sizes. In one example, the beads are 2.8 μm beads. In another example, it may be 1 μm beads. Suspension of 1 μm beads The liquid (e.g., 1 μL) provides a large surface area per volume for transposome binding. The surface area available for transposome binding determines the number of tagmented products per reaction. The number of products increases.
[0037] FIG. 2 illustrates steps 110, 115, and 120 of the method 100 of FIG. In the example shown, the transposon is double stranded. Other examples (not shown) show other structures such as hairpins. structure, i.e., a single oligonucleotide having a self-complementary region capable of forming a double strand. Otides may also be used.
[0038] In step 110 of method 100, a plurality of biotinylated P5 transposons 210a and a plurality of P7 transposons 210b. 7. Biotinylate transposon 210b.
[0039] In step 115 of the method 100, the P5 transposon 210a and the P7 transposon The transposon 210b was mixed with the transposase Tn5 215 to generate multiple assembled transposons. The insposome 220 is formed.
[0040] In step 120 of method 100, transposomes 220 are attached to beads 225. Beads 225 are streptavidin-coated beads. Transposome 2 20 is bound to beads 225 via a biotin-streptavidin binding complex.
[0041] In one embodiment, the mixture of transposomes is Alternatively, the ion exchange reaction may be carried out on a solid support such as the surface of a bead, as shown in FIG. 3. In this example, P5 and The P7 oligonucleotide is first attached to the bead prior to assembly of the transposome complex. Attach to the surface.
[0042] FIG. 3 shows a schematic diagram of an example of a tagmentation process 300 on a bead surface. At 0, the bead 225 of FIG. 2 is shown with the transposome 220 bound thereto. 0 solution is added to the suspension of beads 225. DNA 310 is attached to the transposome 220. Upon contact, the DNA is tagmented (fragmented and tagged) and transformed into a transposome. 220 to the beads 225. The bound and tagmented DNA 310 is then CR amplification may be performed to generate a pool of amplification products 315 in solution (without beads) The amplification products 315 may be transferred to the surface of a flow cell 320. Protocols (e.g., bridge amplification protocols, or can be used for cluster generation) A plurality of clusters 325 are then fused to the flow cell 320 using any other amplification protocol. The clusters 325 may be generated on the surface of a clone of the tagmented DNA 310. Cluster 325 is now ready for the next step in the sequencing protocol. This means that the device is ready for the next round of tests.
[0043] In another embodiment, the transposome is attached to any solid object, such as the wall of a microcentrifuge tube. It may be attached to a body surface.
[0044] In another embodiment of forming a mixture of transposome complexes on the bead surface, The oligonucleotides are first bound to the bead surface prior to transposome assembly. FIG. 10 illustrates an example of a method 1000 for forming transposome complexes on a bead surface. 1 shows a flowchart. The method 1000 includes, but is not limited to, the following steps: .
[0045] In step 1010, the P5 and P7 oligonucleotides are attached to the bead surface. In one example, the P5 and P7 oligonucleotides are biotinylated and the beads are , streptavidin coated beads. This step is also shown in schematic 1100 of FIG. 11, P5 oligonucleotide 1110 and P7 oligonucleotide 1111 are shown. The oligonucleotide 1115 is attached to the surface of the bead 1120. In this example, One P5 oligonucleotide 1110 and one P7 oligonucleotide 1115 are 1120, but any number of P5 oligonucleotides 1110 and and / or P7 oligonucleotide 1115 may be attached to the surface of a plurality of beads 1120. In one example, the P5 oligonucleotide 1110 comprises the P5 primer sequence, The index sequence (unique identifier), the read 1 sequencing primer sequence, and the mosaic In this example, P7 oligonucleotide 1115 contains the P7 Primer sequence, index sequence (unique identifier), read 2 sequencing primer In another example (not shown), the index sequence includes a P 5 is present only in oligonucleotide 1110. The index sequence is present only in P7 oligonucleotide 1115. In the nucleotide sequence not shown, the index sequences are P5 oligonucleotide 1110 and P7 oligonucleotide 1111. It is not present in any of the nucleotide sequences listed in the nucleotide sequence list, nor in any of the nucleotide sequences listed in the nucleotide sequence list, 1115.
[0046] In step 1015, a complementary mosaic end (ME') oligonucleotide is added to the This step also hybridizes to the oligonucleotides P5 and P7. , which is depicted pictorially in diagram 1200 of FIG. 12. Referring now to FIG. 12, the complementary ME sequence ( ME') 1125 is a mixture of P5 oligonucleotide 1110 and P7 oligonucleotide 11 15. Complementary ME sequence (ME') 1125 (e.g., complementary ME sequence Array (ME') 1125a and complementary ME sequence (ME') 1125b) are the P5 oligonucleotides. The ME sequences of oligonucleotides 1110 and 1115 were hybridized to each other. The complementary ME sequence (ME') 1125 is typically about 15 bases long and ' is phosphorylated at the terminus.
[0047] In step 1020, a transposase enzyme is coupled to the bead-bound oligonucleotides. This step also includes adding 100 μl of the ... bead-bound transposome complex to the 100 μl of the bead-bound transposome complex. This is depicted pictorially in diagram 1300 of Figure 13. Referring now to Figure 13, the transposase enzyme is added to form multiple transposome complexes 1310. The transpososome complex 1310 contains a transposase enzyme, two surface-bound oligonucleotides, and The nucleotide sequence of the present invention is a nucleotide sequence of the present invention, and a complementary ME sequence (ME') 1125 hybridized thereto. For example, the transposome complex 1310a has a complementary ME sequence (M E') P5 oligonucleotide 1110 hybridized to 1125 and the complementary ME sequence P7 oligonucleotide 1115 (i.e., P 5:P7), and transposome complex 1310b contains a complementary ME sequence (ME')1 Two P5 oligonucleotides 1110 hybridized to 125 (i.e., P5:P5 ), and the transposome complex 1310c is a complementary ME sequence (ME') 1125. It contains two hybridized P7 oligonucleotides 1115 (i.e., P7:P7). The ratios of 5:P5, P7:P7, and P5:P7 transposome complexes are, for example, 25 :25:50 would also be fine.
[0048] FIG. 14 illustrates the tagmentation process using the transposome-coated beads 1120 of FIG. An exemplary schematic diagram 1400 is shown. In this example, a transposome complex 1310 is The beads 1120 to be tagged are added to a solution of DNA 1410 in tagmentation buffer. The DNA is then transferred to the surface of the beads 1120 via the transposome 1310. The successive tagmentation of DNA1410 results in the formation of the transposome131 The length of the bridge molecule 1415 is equal to the length of the bead 1 This may depend on the density of transposome complexes 1310 on the surface of 120. In one example, the density of transposome complexes 1310 on the surface of beads 1120 is , P5 bound to the surface of bead 1120 in step 1010 of method 100 of FIG. and P7 oligonucleotides. The density of the transposome complexes 1310 on the surface of the beads 1120 is determined by the method of FIG. In step 1015 of 1000, the P5 and P7 oligonucleotides are hybridized. This may be adjusted by varying the amount of complementary ME sequence (ME') that is inserted. In another example, the density of transposome complexes 1310 on the surface of beads 1120 is Varying the amount of transposase enzyme added in step 1020 of the method 1000 of FIG. The adjustment may be performed by adjusting the temperature.
[0049] The length of the bridge molecule 1415 is determined by the length of the transposome complex used in the tagmentation reaction. The amount of the combined beads 1120 does not depend on the amount of the combined beads 1310. Adding more or less DNA1410 in the It does not change the size of the object, but it may affect the yield of the reaction.
[0050] In one example, the beads 1120 are paramagnetic beads. The purification of the reaction can be easily carried out by immobilizing the beads 1120 on a magnet and washing them. Therefore, tagmentation and subsequent PCR amplification can be performed in a single reaction compartment ("one-pot"). The reaction may be carried out in a "one-pot" manner.
[0051] In one embodiment, the present invention provides a method for deriving sequence information of a target nucleic acid on a solid support. The present invention relates to methods and compositions for transposase-based methods capable of In some embodiments, the compositions and methods can derive assembly / phase information. In one embodiment, the solid support is a bead. In one embodiment, the target nucleic acid is DNA. In some embodiments, the target nucleic acid is RNA. In some embodiments, the target nucleic acid is a complementary DNA (cDNA). DNA).
[0052] In some embodiments, the transposon is attached as a dimer to a solid support, such as a bead. Then, transposase is bound to the transposon to form a transposome. It may be possible to do so.
[0053] In some embodiments, the addition of immobilized transposon and transposase With particular reference to the formation of transposomes on a solid phase, two transposons are The electrodes may be fixed in close proximity to each other (preferably at a fixed distance) in the support. This approach has several advantages. First, it is preferable to use two transformers. The linker length and orientation of the poson are optimal for efficient transposome formation. Second, the transposons are always fixed at the same time. The efficiency of genome formation does not appear to be a function of transposon density. The transposons are always aligned in the correct orientation and distance to form a transposome. Third, the ability to bind randomly immobilized transposons on a surface This results in various distances between transposons, so that only one fraction of the transposons are transposable. The optimal direction and distance for efficient formation of sposomes. Instead of the transposon converting into a transposome, the immobilized uncomplexed transposon These transposons have the ME portion made up of double-stranded DNA. This leads to a decrease in the efficiency of the transposition and can lead to undesirable by-products. Therefore, it can be used subsequently to perform tagmentation and sequencing. Transposomes are prepared on a solid support from which connectivity information can be derived through labeling. An exemplary scheme is shown in FIG. The poson may be immobilized on the solid support by a method other than chemical bonding. Exemplary methods for immobilizing amplicons include, but are not limited to, streptavidin. Gin-biotin, maltose-maltose binding protein, antigen-antibody, DNA-DNA or affinity binding such as DNA-RNA hybridization.
[0054] In some embodiments, the transposomes are preassembled and then attached to a solid support. In some embodiments, the transposon can be immobilized in a native The transposase comprises an index, a barcode, and an amplification primer binding site. A transposon that can be added to a solution containing a transposon and immobilized on a solid support. In one embodiment, each set can form a dimer of immobilized tranosomes. The endothelial cells have the same index derived from the endothelial sposon, thereby producing indexed beads. As shown in Figure 29A, multiple bead sets can be generated that each contain a target nucleic acid. can be added to each set of indexed beads.
[0055] In some embodiments, the target nucleic acid is added to each set of indexed beads. Alternatively, tagmentation and subsequent PCR amplification may be performed separately.
[0056] In some embodiments, the target nucleic acid, the indexed beads, and the transposons A droplet is a set of many droplets, each containing one bead and one or more DNA molecules and sufficient transfection. The molecules can be combined in droplets to include sposomes.
[0057] In some embodiments, the indexed beads can be pooled, Target nucleic acid can be added to the reaction chamber, and tagmentation and subsequent PCR amplification can be performed in a single reaction chamber. This may be done in a "one-pot" fashion.
[0058] In one embodiment, the present invention provides a method for the preparation of a ligated transposition target nucleic acid by capturing the ligated transposition target nucleic acid on a solid support. In some embodiments, the present invention relates to a method and composition for deriving continuity information. Contiguity preserving transposition (CPT) ition) is performed on the DNA, which remains intact (CP The sequence information is then transferred to the transposase, which then transfers the T-DNA to the chromosome, thus forming a concatenated library. Association of template nucleic acid fragments adjacent to the target nucleic acid using The CPT-DNA can be preserved by maintaining it on a solid support, e.g. , a complementary oligonucleotide having a unique index or barcode immobilized on the bead. The hybridization of the nucleotide sequence to the nucleotide sequence of the target gene can capture the nucleotide sequence of the target gene (Figure 29B). In one embodiment, the oligonucleotides immobilized on the solid support are labeled with a barcode. In addition, primer binding sites, unique molecular indexes (UMIs), The information may further include ular indices.
[0059] Advantageously, transposomes can thus be used to transduce fragmented nucleic acids. By maintaining the physical proximity of the fragments from molecules of the same origin, e.g., chromosomes, The nucleic acid thus obtained is labeled with the same unique barcode and index information as the oligonucleotide immobilized on the solid support. This increases the chance of receiving a unique barcode from a single oligonucleotide. A linked sequencing library is obtained. The aliquots can be sequenced to extract contiguous sequence information.
[0060] 16 and 17 show the creation of a concatenated library with a unique barcode or index. 1 shows a schematic diagram of an exemplary embodiment of the above aspect of the invention for producing a CPT -DNA and immobilized oligonucleotides on a solid support with unique indexes and barcodes Ligation of nucleotides and strand displacement PCR are used to perform live sequencing. In one embodiment, the clone-indexed beads generate a run. The sequences may be generated with fixed DNA sequences such as dams or specific primers and indexes. The bound library was generated by hybridization to immobilized oligonucleotides and subsequent labeling. By igation, the molecules can be captured on clonally indexed beads. Intramolecular hybridization capture is much faster than intermolecular hybridization Therefore, the continuous transposition library "wraps around" the beads. 18 and 19 show the capture of CPT-DNA on clone-indexed beads. Strand displacement PCR preserves the clonal bead index information for each individual Thus, each ligation library can be specifically indexed. It will be attached.
[0061] In some embodiments, the oligonucleotide immobilized on the solid support is One strand is immobilized on a solid support and the other strand is partially complementary to the immobilized strand. The Y-adapter may include a partially double-stranded structure, such as a Y-adapter formed by the addition of a double-stranded structure. In some embodiments, the Y-adapter immobilized on the solid support is and binds to ligated tagmented DNA by gap-filling, as shown in FIG.
[0062] In some embodiments, the Y-adapter is a probe on a solid support such as a bead. / Index formation through hybridization capture of CPT-DNA FIG. 21 shows an exemplary scheme for making such a Y-adapter. By using these Y-adapters, each fragment can potentially be sequenced. This ensures that the library is a viable candidate for sequencing. The coverage of the
[0063] In some embodiments, the free transposomes are separated from the CPT-DNA. In some embodiments, the separation of free transposomes may be performed by size exclusion chromatography. In one embodiment, the separation is performed using a MicroSpin S-4 00 HR Columns (GE Healthcare, Pittsburgh, PA) The method may be carried out by a method using a system such as Regenerative Life Sciences. 1 shows agarose gel electrophoresis of CPT-DNA isolated from ribosomes.
[0064] There are several methods for capturing the ligated transposition target nucleic acid on a solid support through hybridization. There are several unique advantages to this method. First, the method is hybridization-based. It is based on the hybridization of the two molecules, not on the rearrangement. Therefore, a serially rearranged library of a single target DNA molecule is The possibility of wrapping a unique indexed bead is two or more different single targets. The DNA molecule wraps around a uniquely indexed bead, which is much higher than the In this study, DNA transposition and barcoding of the transposed DNA occur in two separate steps. Third, the assembly of activated transposomes on beads and on solid surfaces This avoids the challenges associated with optimizing the surface density of transposons in First, the autotransposition product can be removed by column purification. Because the transposition DNA contains gaps, the DNA is more flexible and therefore the transpososome This places less strain on the translocation density (insertion size) compared to the method of immobilizing the rheometer on beads. The aim of the method is to develop a combinatorial barcode scheme. Seventh, indexed oligos can be covalently attached to beads. Therefore, there is little possibility of index exchange. The mentation and subsequent PCR amplification may be multiplexed and performed in a single reaction compartment ("one-pot") This can be done in one reaction, eliminating the need to perform individual reactions for each index sequence. become.
[0065] In some embodiments, multiple unique barcodes are encoded throughout the target nucleic acid during translocation. In some embodiments, each barcode may be inserted between fragments. The first barcode sequence includes a first barcode sequence and a second barcode sequence, the first barcode sequence being located at a coding site. The barcode sequence and the second barcode sequence are identified or designed to pair with each other. It is possible to pair the first barcode with the second barcode so that they are related to each other. can be informative. Advantageously, paired The barcode sequence is used to assemble sequencing data from a library of template nucleic acids. For example, a first template nucleic acid including a first barcode sequence and a first and identifying a second template nucleic acid comprising a second barcode sequence that pairs with the barcode sequence of the first template nucleic acid. represents sequences in which the first and second template nucleic acids are adjacent to each other in the sequence representation of the target nucleic acid. Using such a method, it is possible to identify a target nucleic acid without the need for a reference genome. It is possible to assemble sequence representations of a gene de novo.
[0066] In one embodiment, the present invention provides a method for the preparation of shotgun sequenced DNA fragments. The present invention relates to methods and compositions for producing a slurry.
[0067] In one embodiment, the clonal bead index beads are Nucleotide sequences: generated randomly or with specific primers and unique indexes. The target nucleic acid is added to the clonally indexed beads. In some embodiments, The target nucleic acid is DNA. In one embodiment, the target DNA is denatured. NAs are a set of primers containing unique indexes immobilized on a solid surface (e.g., beads). The primer hybridizes to a primer with the same index and then hybridizes to another primer with the same index. The primers on the beads amplify the DNA. One or more further amplifications are then performed. In one embodiment, the amplification may be performed using a 3′ random n-mer sequence. This may be accomplished by whole genome amplification using bead-immobilized primers having the following structure: In an embodiment, the random n-mers prevent primer-primer interactions during amplification. For this purpose, pseudo-complementary bases (2-thiothymine, 2-amino dA, N4-ethylcytosine, etc.) (Hoshika, S; Chen, F; Leal, NA; Benner, SA, A ngew.Chem.Int.Ed.49(32)5554-5557(2010)). FIG. 23 shows an exemplary method for generating a shotgun sequence library of specific DNA fragments. A schematic diagram of the clone-indexed sequencing library and the amplified products is shown. In one embodiment, such a library can be generated. A rally can be generated by a rearrangement. Using the index information as a guide The sequence information of the clone-indexed library is used to assemble the contiguity information. Figure 24 shows a clone-indexed sequencing library. 1 shows an exemplary scheme for assembling sequence information from a library.
[0068] The method of the above embodiment has several advantages. This is much faster than inter-amplification. Therefore, the products on the beads have the same index. It is possible to create a shotgun library of specific DNA fragments. Random primers amplify the template at random locations, so there are A shotgun library can be generated from a particular molecule, having an index The sequence information can be assembled using the attached sequences. The advantage is that reactions can be multiplexed in a single reaction (one-pot reaction), allowing many individual The advantage of this method is that it eliminates the need to use a large number of indexed clone beads. Thus, many different fragments can be uniquely labeled, It is possible to distinguish parental alleles for the same genomic region. This means that the paternal and maternal DNA copies are assigned to the same genomic region. The probability of receiving the same index is low. This takes advantage of the fact that the reaction is much faster than the inter-interface reaction, and the beads are large. It essentially creates a virtual partition in the physical compartment.
[0069] In some embodiments of all of the above aspects of the invention, the method further comprises: It may be used for cfDNA in cell free DNA (cfDNA) assays. In some embodiments, cfDNA is obtained from plasma or placental fluid.
[0070] In one embodiment, plasma is separated whole undiluted using a membrane-based sedimentation-assisted plasma separator. It can be obtained from blood (Liu et al. Anal Chem. 2013 Nov. 5;85(21):10463-70). In one embodiment, the plasma separator The plasma collection zone may include a solid support that includes a transposome. The solid support containing the vesicles is used to separate cf from isolated plasma when the plasma is separated from whole blood. Capture DNA, and / or enrich for cfDNA and / or tagment DNA. In some embodiments, tagmentation can further introduce a unique barcode. The library pool is then demultiplexed by inserting the This would allow for post-sequencing of the sample.
[0071] In some embodiments, the collection zone of the separator contains a PCR master mix (Pla The polymerase may include a polymerase. In one embodiment, the master mix is reconstituted as the plasma exits the separator. In some embodiments, the primer may be in a dry state. In some embodiments, the primers are The specific primers may be used to detect the isolated cfDNA as a result of PCR amplification. The library will be generated directly from plasma.
[0072] In some embodiments, the collection zone of the separator contains an RT-PCR master mix. (primers, nucleotides, buffers, metals), reverse transcriptase, and polymerase. In some embodiments, the primers may be random primers or In some embodiments, the primer is an oligo dT primer. The resulting cDNA can be used for sequencing. Alternatively, the cDNA can be supported on a solid support for sequence library preparation. The cells may be treated with transposomes immobilized on the substrate.
[0073] In some embodiments, the plasma separator is barcoded (1D or 2D barcode) In some embodiments, the separation device includes a blood collection device. This would allow blood to be sent directly to the plasma separator and library preparation device. In some embodiments, the device may include a downstream sequence analyzer. In some embodiments, the sequence analyzer is a single-use sequencer. In this mode, the sequencer queues samples before sequencing them together. Alternatively, the sequencer may be configured to automatically detect the presence of the sample before it is delivered to the sequencing area. The IEEE 802.11b protocol may have a random access function.
[0074] In some embodiments, the collection zone for plasma is configured to concentrate cell-free DNA. , may include a silica matrix.
[0075] Simultaneous detection of phasing and methylation 5-Methylcytosine (5-Me-C) and 5-hydroxymethylcytosine (5-Hydroxymethylcytosine Epigenetic modification (Epi-C), also known as epigenetic modification, is a key regulator of cell metabolism, differentiation, and The present inventors have surprisingly and unexpectedly discovered that IL-1 plays an important role in the development of inflammatory bowel disease and cancer. Moreover, phasing and simultaneous detection of methylation are possible using the methods and compositions of the present application. The present method is based on CPT sequencing on beads (CPT-sequencing). Combining indexed concatenated libraries (eq) with DNA methylation detection For example, the individual libraries generated on the beads can be bisulfite- Treatment with hydrogen salt converts unmethylated C to U, but not methylated C to U. This allows for the detection of 5-Me-C. Through phasing analysis, Epi-methylation-phasing blocks were separated into multiple megabases. It can be established in the area.
[0076] In some embodiments, the size of the DNA to be analyzed ranges from about 100 bases to about several mers. In some embodiments, the size of the DNA to be analyzed is about 100 bases, 200 bases, 300 bases, 400 bases, 500 bases, 600 bases, 700 bases Base, 800 bases, 900 bases, 1000 bases, 1200 bases, 1300 bases, 1500 salts Base, 2000 bases, 3000 bases, 3500 bases, 4000 bases, 4500 bases, 500 0 bases, 5500 bases, 6000 bases, 6500 bases, 7000 bases, 7500 bases, 8 000 bases, 8500 bases, 9000 bases, 9500 bases, 10,000 bases, 10,5 00 bases, 11,000 bases, 11,500 bases, 12,000 bases, 12,500 bases , 13,000 bases, 14,000 bases, 14,500 bases, 15,000 bases, 15, 500 bases, 16,000 bases, 16,500 bases, 17,000 bases, 17,500 salts base, 18,000 bases, 18,500 bases, 19,000 bases, 19,500 bases, 20 ,000 bases, 20,500 bases, 21,000 bases, 21,500 bases, 22,000 Base, 22,500 bases, 23,000 bases, 23,500 bases, 24,000 bases, 2 4,500 bases, 25,000 bases, 25,500 bases, 26,000 bases, 26,50 0 bases, 27,000 bases, 27,500 bases, 28,000 bases, 28,500 bases, 29,500 bases, 30,000 bases, 30,500 bases, 31,000 bases, 31,5 00 bases, 32,000 bases, 33,000 bases, 34,000 bases, 35,000 bases , 36,000 bases, 37,000 bases, 38,000 bases, 39,000 bases, 40, 000 bases, 42,000 bases, 45,000 bases, 50,000 bases, 55,000 salts bases, 60,000 bases, 65,000 bases, 70,000 bases, 75,000 bases, 80 ,000 bases, 85,000 bases, 90,000 bases, 95,000 bases, 100,00 0 bases, 110,000 bases, 120,000 bases, 130,000 bases, 140,00 0 bases, 150,000 bases, 160,000 bases, 170,000 bases, 180,00 0 bases, 200,000 bases, 225,000 bases, 250,000 bases, 300,00 0 bases, 350,000 bases, 400,000 bases, 450,000 bases, 500,00 0 bases, 550,000 bases, 600,000 bases, 650,000 bases, 700,00 0 bases, 750,000 bases, 800,000 bases, 850,000 bases, 900,00 0 bases, 1,000,000 bases, 1,250,000 bases, 1,500,000 bases, 2,000,000 bases, 2,500,000 bases, 3,000,000 bases, 4,00 0,000 bases, 5,000,000 bases, 6,000,000 bases, 7,000,00 0 bases, 8,000,000 bases, 9,000,000 bases, 10,000,000 bases , 15,000,000 bases, 20,000,000 bases, 30,000,000 bases, 40,000,000 bases, 50,000,000 bases, 75,000,000 bases, 1 00,000,000 bases or more.
[0077] 5-hydroxy-C, DNA oxidation products, DNA alkylation products, histone ends (h Other Epi modifications, such as istone-foot printing, can also be used in the methods disclosed herein. The methods and compositions can also be used to analyze in fading.
[0078] In some embodiments, the DNA is first indexed onto a solid support. The resulting library is converted to a single indexed library, which is much smaller than the original DNA. The libraries are less likely to fragment because the individual libraries are smaller. Even if a small fraction of the indexed library is lost, the phasing information is still available. The DNA fragments are still maintained throughout the entire length of the cross-linked DNA molecule. For example, In the case of In the methods disclosed herein, a library of 100 kb can be , initially indexed, and even if individual library fractions disappear, the continuity is still ∼100 kb (in the rare event that the entire library is missing from one end of the DNA molecule, Additionally, the methods disclosed herein avoid the need for conventional bisulfite conversion approaches. In contrast to the need for additional purification steps, the yield is increased. In the method disclosed herein, the beads are After conversion, the DNA is simply washed. Furthermore, the DNA ( Minimal loss of indexed libraries and easy buffer exchange with minimal effort can be carried out.
[0079] An exemplary scheme for simultaneous detection of phasing and methylation is shown in Figure 43. Operational flow The method involves on-bead DNA tagmentation, gap-filling ligation of 9-base pair repeat regions, and Removal of Tn5 with SDS and bisulfite conversion of individual libraries on beads To ensure that adjacent complementary libraries do not reanneal, Bisulfite conversion is carried out under denaturing conditions, thereby reducing the efficiency of bisulfite conversion. BSC converts unmethylated C to U and leaves methylated C unconverted.
[0080] Figure 44 shows another exemplary scheme for simultaneous detection of phasing and methylation. Later, after preparing the sequencing library, the gap was cut to prepare single-stranded templates. The fragment of the ligated library is digested. The single-stranded template is digested. One possibility is to reduce library loss or improve bisulfite conversion efficiency. Because it is double-stranded, it requires milder conditions for bisulfite conversion. In terms of morphology, 3' thio-protected transposons (Exo-resistant) and non-protected transposons A mixture of the above is used on the same beads. The thio-protected thiol groups can be decomposed into single-stranded libraries and converted into single-stranded libraries. By using a 50:50 mixture of transposons:non-protected transposons, Convert 50% of the library into a single-stranded library (50% means one of the libraries is One transposon is protected and one transposon (complementary strand) is not protected ), 25% did not convert (both transposons were thio-protected), and 25% did not convert (both transposons were thio-protected). also transform 100-fold to remove the entire library (both transposons are unprotected).
[0081] To perform bisulfite conversion of DNA bound to a solid phase such as streptavidin magnetic beads One challenge is to heat the beads with DNA bound to them for long periods at high temperatures using sodium bisulfite. The short-term treatment damages both the DNA and the beads. To aid in recovery, carrier DNA (i.e., lambda DNA) was added to the reaction mixture prior to bisulfite treatment. Even if carrier DNA is present, approximately 80% of the original DNA is lost. As a result, the CPTSeq continuity block is It has fewer members than the
[0082] Thus, herein, we aim to improve the DNA yield of the Epi-CPTSeq protocol. We propose several strategies for this purpose. The first strategy is to use streptavidin By packing the transposome complexes more closely on the beads, the library insert size can be reduced. By reducing the library size, a smaller proportion The library elements are degraded by bisulfite treatment.
[0083] A second strategy to improve DNA yields in the Epi-CPTSeq protocol is The restoration strategy is to enzymatically restore the damaged library elements. The purpose of this is to cleave the 3' consensus sequence required for library amplification by cleaving the 3' portion during bisulfite treatment. The goal is to re-add bead-bound library elements that have been degraded and lost. After adding the common sequences, these elements can be PCR amplified and sequenced. Figures 67 and 68 show an exemplary scheme of this strategy. Seq library elements are denatured and bisulfite converted (top). During conversion, one of the DNA strands is damaged (middle), resulting in the loss of the PCR consensus sequence on the 3' end. The template rescue strategy restores the 3' consensus sequence (green) required for PCR amplification. In one example, a 3' phosphorylated attenuator oligo, i.e., In the presence of a sequence containing a sequencing adaptor followed by an oligo-dT stretch, Briefly, TdT is used at 10-15 A stretch of dA is annealed to the oligo dT portion of the attenuator oligo. The formation of this DNA hybrid results in the formation of the Td The T reaction is stopped and the 3' ends of the broken library elements are ligated by DNA polymerase. This provides a template for subsequent extension.
[0084] In another procedure (Figure 68B), the TdT tailing reaction is carried out by splitting the single-stranded oligo dT moiety and and 5' phosphorylated double-stranded sequencing adaptor moieties. At the end of the TdT reaction, the final dA and 5' phosphate are added. The nick between the cleaved attenuator oligo is sealed with DNA ligase.
[0085] Both of the described workflows rely on the recently developed controllable TdT tailing reaction. This is based on and described in U.S. Patent Application Publication No. 2015 / 0087027. The consensus sequencing adapters also support the recently introduced ssDNA template of MMLV RT. The type-switching activity allows addition to the 3' end of the broken library element. In other words, MMLV RT and template switch oligo (TS oligo) switch_oligo) is added to the damaged DNA (Figure 68C). In this step, reverse transcriptase produces several additional fragments at the 3' end of the single-stranded DNA fragments. These bases are added to the 3′ end of one of the TS oligos. The nucleotide sequence is then paired with the oligo(N) sequence, and the nucleotide sequence is converted to aniline by the template switching activity of reverse transcriptase. The sequence of the common primer that was broken down is added to the 3' end of the BSC-broken library element. and restores the ability to be amplified by PCR with common sequencing primers.
[0086] As part of the third strategy, Epicentre's EpiGenome kit A “post-bisulfite conversion” library construction method was used to cleave the 3'-terminus during bisulfite conversion. It is possible to rescue library elements that have lost their terminal consensus sequences. Thus, this library rescue method involves the generation of a consensus sequence followed by a short stretch of random sequences. These short random sequences are then used to generate 3' phosphorylated oligos with the following sequence: The hybridization to salt-treated single-stranded DNA is followed by the amplification of the consensus sequence by DNA polymerase. It is replicated onto the broken library strand.
[0087] Figure 74 shows a fourth strategy for improving on-bead bisulfite sequencing. The first common sequence, which contains the capture tag, is covalently attached to the 5' end of the DNA. The consensus sequence can be obtained by one-sided transposition (as shown), adapter ligation, or the method described in U.S. Pat. Terminal transferase (T It can be attached to DNA using a variety of methods, including dT) adapter ligation. can.
[0088] The DNA is then denatured (e.g., by incubation at high heat) and bound to a solid support. If biotin is used as the capture tag on CS1, for example, the DNA is Binding can be accomplished using leptoavidin magnetic beads (as shown). Once bound, buffer exchange can be easily performed.
[0089] In the next step, bisulfite conversion of the ssDNA is carried out. In single-stranded form, DNA A should be readily available for bisulfite conversion and is available from Promega as Methy Conversion efficiencies up to 95% were observed using a modified version of the l Edge BSC kit (Figure 75).
[0090] After bisulfite conversion, a second consensus sequence is attached to the 3' end of the ssDNA bound to the solid support. Several methods for covalently attaching oligos to ssDNA are described above. Using the TdT attenuator / adapter ligation method, we have achieved >95% As a result, the proposed methyl sequencing (Met The yield of the final library using the (hylSeq) workflow is higher than that of existing methods. It should be.
[0091] In the final step, PCR is performed to amplify the library and transfer the library to a solid support. PCR primers are designed to remove additional common sequences such as sequencing adapters. A string can be designed to be added to the end of a MethylSeq library. do.
[0092] Preparation of libraries of various sizes in a single assay The accuracy of genome assembly depends on the use of techniques at a variety of length scales, e.g. Shotgun (a few hundred bp) - Mate pair (~3Kb) - Hi-C (Mb scale) All are methods for improving assembly and contig length over time. The challenge is to do this. Multiplex assays are required to achieve this, making the multi-layer approach cumbersome and expensive. The compositions and methods disclosed herein allow for the detection of multiple length fragments in a single assay. Can accommodate scale.
[0093] In some embodiments, library preparation is performed using solid supports of different sizes, e.g. For example, this can be accomplished in a single assay using beads. The size of each bead is The physical size of the library determines the library size, and a particular library size or size range is All the different sized beads will result in a unique range of molecules that will be transferred to the library. Thus, libraries of various sizes have unique indexes. Each library is generated with different scale lengths, each tagged with a different length scale. Libraries are prepared simultaneously in the same physical compartment, reducing costs and streamlining the entire workflow. In some embodiments, each particular solid support size, e.g., bead size, In some other embodiments, the same solid support receives a unique index. Different indexes of the same bead size, e.g., can also be prepared. In this way, multiple DNA molecules can be indexed according to their size range. 45 was performed in a single assay using various sizes of clone-indexed beads. 1 shows an exemplary scheme for generating libraries of suitable sizes.
[0094] In some embodiments, the size of the libraries generated is about 50 bases, 75 Base, 100 bases, 150 bases, 200 bases, 250 bases, 300 bases, 350 bases, 4 00 bases, 500 bases, 600 bases, 700 bases, 800 bases, 900 bases, 1000 bases Base, 1200 bases, 1300 bases, 1500 bases, 2000 bases, 3000 bases, 350 0 bases, 4000 bases, 4500 bases, 5000 bases, 5500 bases, 6000 bases, 6 500 bases, 7000 bases, 7,500 bases, 8000 bases, 8500 bases, 9000 bases base, 9500 bases, 10,000 bases, 10,500 bases, 11,000 bases, 11,5 00 bases, 12,000 bases, 12,500 bases, 13,000 bases, 14,000 bases , 14,500 bases, 15,000 bases, 15,500 bases, 16,000 bases, 16, 500 bases, 17,000 bases, 17,500 bases, 18,000 bases, 18,500 salts base, 19,000 bases, 19,500 bases, 20,000 bases, 20,500 bases, 21 ,000 bases, 21,500 bases, 22,000 bases, 22,500 bases, 23,000 Base, 23,500 bases, 24,000 bases, 24,500 bases, 25,000 bases, 2 5,500 bases, 26,000 bases, 26,500 bases, 27,000 bases, 27,50 0 bases, 28,000 bases, 28,500 bases, 29,500 bases, 30,000 bases, 30,500 bases, 31,000 bases, 31,500 bases, 32,000 bases, 33,0 00 bases, 34,000 bases, 35,000 bases, 36,000 bases, 37,000 bases , 38,000 bases, 39,000 bases, 40,000 bases, 42,000 bases, 45, 000 bases, 50,000 bases, 55,000 bases, 60,000 bases, 65,000 salts bases, 70,000 bases, 75,000 bases, 80,000 bases, 85,000 bases, 90 ,000 bases, 95,000 bases, 100,000 bases, 110,000 bases, 120, 000 bases, 130,000 bases, 140,000 bases, 150,000 bases, 160, 000 bases, 170,000 bases, 180,000 bases, 200,000 bases, 225, 000 bases, 250,000 bases, 300,000 bases, 350,000 bases, 400, 000 bases, 450,000 bases, 500,000 bases, 550,000 bases, 600, 000 bases, 650,000 bases, 700,000 bases, 750,000 bases, 800, 000 bases, 850,000 bases, 900,000 bases, 1,000,000 bases, 1, 250,000 bases, 1,500,000 bases, 2,000,000 bases, 2,500, 000 bases, 3,000,000 bases, 4,000,000 bases, 5,000,000 salts bases, 6,000,000 bases, 7,000,000 bases, 8,000,000 bases, 9, 000,000 bases, 10,000,000 bases, 15,000,000 bases, 20,0 00,000 bases, 30,000,000 bases, 40,000,000 bases, 50,00 0,000 bases, 75,000,000 bases, 100,000,000 bases, or more Above.
[0095] In some embodiments, the library of multiple length scales described above is Instead, they have large length scales and can be used to assemble pseudogenes, paralogs, etc. In some embodiments, libraries of multiple length scales can be generated in a single array. The advantage is that at least one length scale is similar to that of a pseudogene or a genetic The goal of this length scale is to bind to unique regions that have only the chromosome and not both. Mutations detected by the test can be uniquely assigned to either genes or pseudogenes. The same applies to copy number variations, paralogs, etc. The advantages of assembly are By using the methods disclosed herein, different length scales can be used. A library of indexed bonds for all length scales is created with individual bonds for different length scales. These can be generated in a single assay, without multiple separate library preparations. Figure 4 Figure 6 shows an exemplary scheme for determining genetic variations in libraries of different length scales. vinegar.
[0096] Analysis of gene mutations The compositions and methods disclosed herein relate to the analysis of genetic mutations. Variations include, but are not limited to, deletions, interchromosomal rearrangements, duplications, paralogs, interchromosomal genes, and In some embodiments, the compositions and methods disclosed herein include gene fusions. The method involves determining phasing information for genetic variations. The following table shows exemplary interchromosomal genes. Indicates gene fusion.
[0097] [Table 1]
[0098] Table 2 shows exemplary deletions in chromosome 1.
[0099] [Table 2]
[0100] In some embodiments, the target nucleic acid is fused to a transposome prior to exposing the target nucleic acid to the transposome. Exemplary fragmentation methods include, but are not limited to, However, other methods include sonication, mechanical shearing, and restriction digestion. Fragmentation of the target nucleic acid prior to targeting and tagging can be used to identify pseudogenes (e.g., CYP2D6 ) assembly / phasing. Long islands of indexed combined reads (> The 30 kb region of the sequence would span pseudogenes A and A', as shown in Figure 64. Because of the homozygote nature, the challenge is to determine which mutations belong to gene A and which belong to gene A'. The shorter mutation will bind to one of the mutations in the pseudogene with unique surrounding sequences. Such shorter islands may be useful for target nucleic acid fragmentation prior to tagmentation. More can be achieved.
[0101] Binding transposomes In some embodiments, the transposase is abundant in the transposome complex. The present invention is a complex that forms, for example, a dimer, a tetramer, etc. in a transposome complex. The authors surprisingly and unexpectedly found that the monomers in the multimeric transposome complex Binding the transposase or binding the transposase to the multimeric transposome complex We have found that combining the transposon ends of the endoplasmic reticulum monomers has several advantages. First, the binding of the transposase or transposon is more stable. Second, at lower concentrations, a large fraction of the complexes are in an active state. Possibility of using transposomes in fragmentation by transposition reactions Third, binding may result in the formation of mosaic ends (MEs) of the transposome complex. There will be less exchange of barcodes and therefore less mixing of barcode or adapter molecules. Such exchange of ME termini occurs when the complex disassembles and reassembles, or when the transmembrane domain is transformed into a complex. Sposomes are immobilized on a solid support by streptavidin / biotin, and streptavidin is If the avidin / biotin interaction is broken and reformed, or if there is a possibility of contamination, The inventors of the present application have demonstrated that ME I noticed that there was a significant swap or exchange at the end. In an embodiment, the exchange can be up to 15%. The difference in the ME exchange rate is significant in the glutamate buffer and decreases in the glutamate buffer. Several possible mechanisms are presented.
[0102] In some embodiments, the subunits of the transposase in the transposome complex The units can be bonded to one another by covalent and non-covalent means. In this state, transposase monomers are separated into two subunits (transpososome complexes) before forming the transposome complex. In some embodiments, the transposon may be added to the The transposase monomers can be bound after formation of the transposome.
[0103] In some embodiments, the natural amino acid residues at the multimer interface are cysteine (Cys). The amino acids may be substituted to promote disulfide bond formation. In the sposase, Asp468, Tyr407, Asp461, Lys459, and S The er458, Gly462, Ala466, and Met470 were replaced with Cys to form a monomeric subunit. Disulfide bonds between the subunits may be promoted. With respect to the -1 transposase, exemplary amino acids that can be substituted with cysteine are: Examples include, but are not limited to, Leu21, Leu32, Ala35, His20, P he17, Phe36, Ile16, Thr13, Arg12, Gln10, and Glu9 As shown in Figure 61. In some embodiments, cysteine-substituted amino acids are Modified transposases bearing a maleimide or pyridyldithiol reactive group The chemical crosslinkers used can be used to chemically crosslink each other. The reagent was Pierce Protein Biology / ThermoFisher S It is commercially available from Scientific Inc. (Grand Island, NY, USA).
[0104] In some embodiments, the transposome multimeric complex is covalently attached to a solid support. Exemplary solid supports include, but are not limited to, nanoparticles. In some embodiments, the surface of the matrix may be a bead, a flow cell surface, or a column matrix. In some cases, the solid surface may be coated with amine groups. Modified transposases that have residues that react with amine-sulfhydryl groups on such amine groups. aryl crosslinker (i.e., succinimidyl-4-(N-maleimidomethyl)cyclohexane- 1-carboxylate (SMCC). A typical scheme is shown in Figure 62. In some embodiments, maleimide-PEG-biotin is dTnp may be bound to a streptavidin-coated solid surface using a streptavidin crosslinker.
[0105] In some embodiments, the transposase gene is expressed in large amounts in a single polypeptide. For example, Tn5 or Mos-1 can be modified to express a target protein. The gene is designed to express two Tn5 or Mos-1 proteins in a single polypeptide. Similarly, the Mu transposase gene can be modified to encode a single polypeptide. The vector can be modified to encode four mu transposase units.
[0106] In some embodiments, the transposon ends of the transposome monomer units are ligated. The transposons can be combined to form a bound transposome multimeric complex. By joining the ends, a primer site can be inserted, allowing sequencing. A primer, an amplification primer, or any role DNA fragments the target DNA. Such functional insertions can be used to manipulate gDNA without fragmenting it. Information needs to be extracted from intact molecules or subsampling is important, This is an advantage in a PCR assay or a binding site tagged assay. The transposon ends of the Mu transposome are then transformed into "looped" Mu transposers. Mu is a tetramer and can be bound to the enzyme / transposon structure. including, but not limited to, binding R2UJ and / or R1UJ to R2J and / or R1J In these structures, R2UJ and R1UJ are R 2J and R1J, which may or may not be combined. 1 shows a Mu transposome complex with bound poson ends. , the transposon ends of Tn5 or Mos-1 transpososomes , can be combined.
[0107] As used herein, the term "transposon" refers to a gene that is capable of carrying out an in vitro transposition reaction. The nucleic acid required to form a complex with a transposase or integrase enzyme that functions The term refers to double-stranded DNA that shows only the primer sequence (the "transposon end sequence"). The transposon is a nucleotide sequence that recognizes and binds to the transposon, and is either a transposase or an integrase. The enzyme is also referred to as a "complex" or a "synaptic complex" or a "transposome complex" or The complex forms a "transposome composition." The complex is The transposon can insert or transpose into the target DNA that is incubated with the Transposons consist of a "transferred transposon sequence" or "transfer strand" and a "transferred The two complementary sequences consisting of the "non-transferred transposon sequences" or "non-transferred strands" are shown. For example, the hyperactive Tn5 transposase is active in in vitro transposition reactions. (See, e.g., EZ-Tn5™ Transposase, Madison, Wisconsin, USA. 1) forms a complex with The two transposons are transferred strands that exhibit the following "transferred transposon sequence": 5'AGATGTGTATAAGAGACAG3' and the non-transferred strand exhibiting the following "non-transferred transposon sequence": 5'CTGTCTCTTATACACATCT3' Includes.
[0108] The 3' end of the transferred strand binds or transfers to the target DNA in an in vitro transposition reaction. The non-transferred strand exhibits a transposon sequence complementary to the transferred transposon end sequence, In an in vitro transposition reaction, it does not bind to or transpose to target DNA. In some embodiments, the transposon sequence includes one or more of the following sequences: Also suitable: barcode, adapter sequence, tag sequence, primer binding sequence, capture sequence, unique Unique molecular identifier (UMI) sequence.
[0109] As used herein, the term "adapter" refers to a barcode, a primer binding sequence, a capture A capture sequence, a sequence complementary to the capture sequence, a unique molecular identifier (UMI) sequence, an affinity moiety, and a restriction site. It means a nucleic acid sequence which can include
[0110] As used herein, the term "continuity information" refers to the integration of two or more This refers to the spatial relationship between the DNA fragments above. The manner in which information is shared is through adjacent relationships and compartment relationships. , and metric spatial relations. Information about these relations is In addition, it facilitates the hierarchical assembly or mapping of sequence reads derived from DNA fragments. This contiguity information improves the efficiency and accuracy of such assembly or mapping. This is because the traditional methods used in conjunction with conventional shotgun sequencing In assembly or mapping methods, two or more DNA fragments from which individual sequence reads are derived are identified. The relative genomic origin or coordinates of individual sequence reads with respect to the spatial relationship of the A fragment Therefore, according to the embodiment described herein, the continuity information is not taken into account. The method of capturing information is the short-distance continuity method to determine adjacent spatial relations, and the method of determining the spatial relations of blocks. This may be done by a medium-distance continuity method, or a long-distance continuity method to determine metric spatial relationships. The methods described herein improve the accuracy and quality of DNA sequence assembly or mapping. This method may be used in conjunction with any sequencing method, such as those described above. stomach.
[0111] Contiguity information indicates the sequence of two or more DNA fragments from which individual sequence reads are derived. With respect to spatial relationships, this includes the relative genomic origin or coordinates of individual sequence reads. In an embodiment, the contiguous information comprises sequence information from non-redundant sequence reads.
[0112] In some embodiments, the contiguous information of the target nucleic acid sequence represents haplotype information. In some embodiments, the contiguous information of the target nucleic acid sequence is indicative of genomic mutations.
[0113] As used herein, the term "maintaining the continuity of the target nucleic acid" refers to the prevention of nucleic acid fragmentation. In this context, it is intended to maintain the order of nucleic acid sequences of fragments from the same target nucleic acid. Taste.
[0114] As used herein, the term "at least a portion" and / or its grammatical equivalents means the entire amount For example, "at least a portion" means at least a small amount of the total. Each is approximately 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 15%, 20%. %, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70 %, 75%, 80%, 85%, 90%, 95%, 99%, 99.9%, or 100%. It is possible.
[0115] As used herein, the term "about" means ±10%.
[0116] As used herein, the term "sequencing read" and / or its grammatical equivalents. is a physical or chemical technique that is used to obtain signals that indicate the order of monomers in a polymer. The signal can be at single monomer resolution or at lower resolution. In certain embodiments, the steps include: This can be done starting with an acid target and obtaining a signal that indicates the order of bases in the nucleic acid target. A process can be performed to typical completion, which typically means that the process The signal is no longer able to distinguish the target bases with a reasonable level of certainty. If desired, e.g., until a desired amount of sequence information is obtained, A sequencing read is a sequence of a single target nucleic acid molecule. or simultaneously for a group of target nucleic acid molecules having the same sequence, or for targets having different sequences. In some embodiments, sequencing can be performed on a group of nucleic acids simultaneously. The gradient is the time when a signal is detected from one or more target nucleic acid molecules at which signal acquisition is initiated. For example, a sequencing read is terminated when no more can be obtained from the solid phase. The method starts with one or more target nucleic acid molecules present on the substrate and detects one or more target nucleic acid molecules. The sequence can be terminated when the target nucleic acid molecule is removed from the substrate. The tagging process stops the detection of target nucleic acids that were present on the substrate when the sequencing run began. An exemplary sequencing method can be completed in its entirety by No. 9,029,103, which is incorporated herein by reference. is.
[0117] As used herein, the term "sequencing representation" and / or its grammatical equivalents , can refer to information that indicates the order and type of monomer units in a polymer. For example, can indicate the order and type of nucleotides in a nucleic acid. Any content, including images, electronic media, a series of symbols, a series of numbers, a series of letters, a series of colors, etc. The information may be in a variety of formats. The information may be at single monomer resolution or at lower resolution. An exemplary polymer is a nucleic acid such as DNA or RNA having nucleotide units. A series of "A", "T", "G", and "C" letters represent DNA at single nucleotide resolution. It is a well-known sequence representation for DNA that correlates with the actual sequence of the molecule. Suitable polymers are proteins, which have amino acid units, and polysaccharides, which have sugar units.
[0118] solid support Throughout this specification, solid support and solid surface are used interchangeably. In one embodiment, the solid support or its surface is a non-transparent surface, such as the interior or exterior surface of a tube or vessel. In some embodiments, the solid support is a microsphere or bead. As used herein, the term "microsphere" or "bead" or "particle" or its grammar may be used. By "particle-based" we mean small dispersed particles. Suitable bead compositions include, but are not limited to: No, but plastic, ceramic, glass, polystyrene, methylstyrene, acrylic Polymers, paramagnetic substances, thoria sol, carbon graphite, Titanium dioxide, latex, or cross-linked dextran such as Sepharose, cellulose, nano Examples of solid supports include styrene, cross-linked micelles, and teflon, also generally referred to herein as solid supports. Any other materials described herein may be used. Microsphere Detection Guide from Microspheres, Inc. (Fishers, Indiana) The Network Threat Prevention Guide is a useful guide. In embodiments, the microspheres are magnetic microspheres or beads. In an embodiment, the beads may be color coded. MicroPlex® microspheres (Austin, SUS) may also be used. .
[0119] The beads need not be spherical; irregular particles may be used. Alternatively or in addition, The beads may be porous. The size of the beads is in nanometers, i.e. about 10 nm in diameter. From millimeters, i.e. 1 mm, beads from about 0.2 microns to about 200 microns Beads of about 0.5 to about 5 microns are preferred, and beads of about 0.5 to about 5 microns are particularly preferred, although in some embodiments In some embodiments, smaller or larger beads may be used. The beads are available in diameters of approximately 0.1 μm, 0.2 μm, 0.3 μm, 0.4 μm, 0.5 μm, 0 .6μm, 0.7μm, 0.8μm, 0.9μm, 1μm, 1.5μm, 2μm, 2.5 μm, 2.8μm, 3μm, 3.5μm, 4μm, 4.5μm, 5μm, 5.5μm, 6 μm, 6.5μm, 7μm, 7.5μm, 8μm, 8.5μm, 9μm, 9.5μm, 1 0μm, 10.5μm, 15μm, 20μm, 25μm, 30μm, 35μm, 40μm , 45μm, 50μm, 55μm, 60μm, 65μm, 70μm, 75μm, 80μm , 85μm, 90μm, 95μm, 100μm, 150μm, or even 200μm good.
[0120] Transposome "Transposome" refers to an integration enzyme such as integrase or transposase. and a nucleic acid containing an integration recognition site, such as a transposase recognition site. In the embodiments provided herein, the transposase catalyzes a transposition reaction. It is capable of forming a functional complex with a transposase recognition site that is capable of Transposases catalyze the synthesis of transposase fragments in a process sometimes called "tagmentation." The transposase may bind to a transposase recognition site and insert the transposase recognition site into the target nucleic acid. In some such integration events, one strand of the transposase recognition site In one example, the transposome comprises two subunits. Another example is a dimeric transposase that contains two non-contiguous transposon sequences. In the present study, the transposome contains a dimeric transposase that contains two subunits. The transposase includes a sequence including a transposase sequence and a contiguous transposon sequence.
[0121] Some embodiments include hyperactive Tn5 transposases and Tn5-type transposases. -ase recognition site (Goryshin and Reznikoff, J.Biol.Che m., 273:7367(1998)), or MuA transposase, and R1 and Mu transposase recognition site including R2 terminal sequence (Mizuuchi, K., Cell ,35:785,1983;Savilahti,H,etal.,EMBOJ.,14 :4893, 1995). Exemplary transposase recognition sites that form a complex with the transposase (e.g., EZ-Tn5 (Trimethylation ) Transposase, Epicentre Biotec, Madison, WI hnologies) is a 19-base transfer strand (sometimes referred to as "M" or "ME") with Non-transferred strand: 5′AGATGTGTATAAGAGACAG3′, 5′CTGT The ME sequence may also be optimized by those skilled in the art. may be used.
[0122] Transgenics that can be used with certain embodiments of the compositions and methods provided herein Further examples of host systems include Staphylococcus aureus. reus)Tn552(Colegio et al.,J.Bacteriol.,1 83:2384-8,2001;Kirby C et al.,Mol.Microb iol.,43:173-86,2002), Ty1(Devine & Boeke, Nu cleic Acids Res., 22:3765-72, 1994, and International Publication No. 95 / 23875), transposon Tn7 (Craig, NL, Science. 271:1512,1996;Craig,NL,Review in:Curr T op Microbiol Immunol.,204:27-48,1996), Tn / O and IS10 (Kleckner N, et al., Curr Top Micr obiol Immunol.,204:49-82,1996), Mariner Transpo Zase (Lampe DJ, et al., EMBO J., 15:5470-9,1 996), Tc1(Plasterk RH,Curr.Topics Microb Immunol., 204:125-43, 1996), P element (Glo or,GB,Methods Mol.Biol.,260:97-114,2004 ), Tn3(Ichikawa & Ohtsubo,J Biol.Chem.265 :18829-32,1990), bacterial insertion sequence (Ohtsubo & Sekine, Cu rr.Top.Microbiol.Immunol.204:1-26,1996), Retroviruses (Brown, et al., Proc Natl Acad Sci USA, 86:2525-9, 1989), and yeast retrotransposons (Boek e&Corces, Annu Rev Microbiol.43:403-34,19 89) Further examples include IS5, Tn10, Tn903, IS911, Oxalis (Sleeping Beauty), SPIN 、 hAT, piggyback (Pi ggyBac), Hermes, TcBuster, Ae AeBuster1, Tol2, and the engineered transposase family Enzymes (Zhang et al., (2009) PLoS Genet. 5: e1000 689.Epub 2009 Oct 16;Wilson C.et al(2007 ) J. Microbiol. Methods 71:332-5).
[0123] Further examples of integrase that can be used with the methods and compositions provided herein include Examples of such genes include retroviral integrase and Examples of such integrase recognition sequences include those for HIV-1, HIV-2, SIV, Examples include PFV-1 and RSV integrase.
[0124] Barcode Generally, a barcode is used to identify one or more specific nucleic acids. The barcode may include one or more nucleotide sequences capable of Alternatively, the sequences may be naturally occurring sequences generated upon transposition, e.g., sequences that have previously been aligned. Identical flanking genomic DNA sequences (g-code) at the ends of the DNA fragments etc. In some embodiments, the barcode is absent from the target nucleic acid sequence. It is an artificial sequence that can be used to identify one or more target nucleic acid sequences.
[0125] The barcodes are at least about 1, 2, 3, 4, 5, 6, 7, 8, 9 , 10 pieces, 11 pieces, 12 pieces, 13 pieces, 14 pieces, 15 pieces, 16 pieces, 17 pieces, 18 pieces, 19 pieces In some embodiments, the sequence may include 20, 30, 40, 50, 60, 70, 80, 90, 100, 120, 140, 160, 180, 190, 200, 210, 220, 230, 240, 250, 260, 270, 280, 300, 310, 3 In some embodiments, the barcodes are at least about 10, 20, 30, 40, 50, 6 Contains 0, 70, 80, 90, 100 or more consecutive nucleotides In some embodiments, at least one of the barcodes in the population of nucleic acids that includes a barcode In some embodiments, at least about 10 of the barcodes are different. %, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 99 % are different. In further such embodiments, all of the barcodes are different. In a population of nucleic acids that contain barcodes, the diversity of different barcodes may be determined randomly or Can be non-randomly generated.
[0126] In some embodiments, the transposon sequence comprises at least one barcode. In some embodiments, such as a transposome that includes two non-contiguous transposon sequences. The first transposon sequence comprises a first barcode and the second transposon sequence comprises In some embodiments, the transposon sequence comprises a second barcode. The embodiment includes a barcode that includes a first barcode sequence and a second barcode sequence. In some embodiments, the first barcode sequence is paired with a second barcode sequence. For example, proteins that are known to pair with each other can be identified or designed to A lookup table containing a plurality of first and second barcode sequences is used to identify a known first barcode sequence. It is possible to know which string will be paired with a known second barcode sequence.
[0127] In another example, the first barcode sequence comprises the same sequence as the second barcode sequence. In another example, the first barcode sequence may be the reverse complement of the second barcode sequence. In some embodiments, the first barcode sequence and the second barcode sequence may include The barcode sequences of the first and second barcode sequences are different. ode).
[0128] In some embodiments of the compositions and methods described herein, the barcode is Naturally, the vast number of available barcodes allows for the identification of each The template nucleic acid molecules can include a unique identifier. Unique identification can be used for several purposes. For example, uniquely identified molecules can be used to For example, haplotype sequencing, parental allele discrimination, metagenomic sequencing For sequencing of genome samples, samples with multiple chromosomes Applications include the identification of individual nucleic acid molecules in genomes, cells, cell types, cellular diseases, and species. It is possible.
[0129] Exemplary barcode sequences include, but are not limited to, TATAGCCT, ATA GAGGC, CCTATCCT, GGCTCTGA, AGGCGAAG, TAATCTT A, CAGGACGT, and GTACTGAC.
[0130] Primer site In some embodiments, the transposon sequence is a "sequencing adapter " or "sequencing adapter site," in other words, a site that hybridizes to the primer. Some of the sequences may include a region that contains one or more sites that can be scanned. In an embodiment, the transposon sequence is at least one sequence useful for amplification, sequencing, etc. Both sequences can include a first primer site. Exemplary sequences for the sequence binding site include: This includes, but is not limited to, AATGATACGGGCGACCACCGAGATCTACAC (P5 sequence) and CAAGCAGAAGACGGCATACGAGAT (P7 sequence) were Can be obtained.
[0131] target nucleic acid The target nucleic acid can be any nucleic acid of interest. A, RNA, peptide nucleic acid, morpholino nucleic acid, locked nucleic acid, glycol nucleic acid, threo source nucleic acid, mixed sample of nucleic acid, polyploid DNA (i.e. plant DNA), mixtures thereof, and hybrids thereof. In a preferred embodiment, genomic D In another preferred embodiment, the nucleic acid is amplified by the nucleic acid c. In some embodiments, DNA, mitochondrial DNA, or chloroplast DNA is used. In this case, the target nucleic acid is mRNA.
[0132] In some embodiments, the target nucleic acid is derived from a single cell or a fraction of a single cell. In some embodiments, the target nucleic acid is from a single organelle. Representative single organelles include, but are not limited to, a single nucleus, a single mitochondrion, In some embodiments, the target nucleic acid is In some embodiments, the sample is derived from a formalin-fixed, paraffin-embedded (FFPE) sample. In some embodiments, the target nucleic acid is a crosslinked nucleic acid. In some embodiments, the target nucleic acid is cross-linked DNA. In some embodiments, the target nucleic acid is histone-protected DNA. In embodiments, histones are removed from the target nucleic acid. In some embodiments, the target nucleic acid is derived from a nucleosome. It is derived from nucleosomes from which nuclear proteins have been removed.
[0133] The target nucleic acid can include any nucleotide sequence. In some embodiments, Thus, the target nucleic acid contains homopolymeric sequences. The target nucleic acid may also contain repetitive sequences. The repeat sequence can be, for example, 2 nucleotides, 5 nucleotides, 10 nucleotides, , 20 nucleotides, 30 nucleotides, 40 nucleotides, 50 nucleotides, 100 nucleotides, 250 nucleotides, 500 nucleotides, 1000 nucleotides, or Repeated sequences can be of any of a variety of lengths, including longer. Then, for example, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, There can be any variety of repetitions, including 20 or more.
[0134] Some embodiments described herein can use a single target nucleic acid. Other embodiments may use multiple target nucleic acids. The multiple target nucleic acids may be multiple identical target nucleic acids, or multiple nucleic acids in which some of the target nucleic acids are the same. The target nucleic acid may be a plurality of target nucleic acids, each of which is different from the others, or all of which are different from each other. Embodiments using multiple target nucleic acids can be used, for example, in one or more chambers or arrays. This can be done in a multiplexed format so that reagents are simultaneously delivered to target nucleic acids on the surface. In some embodiments, the plurality of target nucleic acids includes substantially all of the genome of a particular organism. Examples of the multiple target nucleic acids include at least about 1% of the genome, 5%, 10%, 25%, 50%, 75%, 80%, 85%, 90%, 95%, or 99% The present invention can include at least a portion of the genome of a particular organism, including In some embodiments, the portion comprises at most about 1%, 5%, 10%, 25%, 50%, 75%, or 80% of the genome. %, 80%, 85%, 90%, 95%, or 99%.
[0135] The target nucleic acid can be obtained from any source. For example, the target nucleic acid can be derived from a single organism. Nucleic acid molecules obtained from the body or from natural sources, including one or more living organisms. The nucleic acid molecule may be prepared from a population of molecules. Sources of the nucleic acid molecule include, but are not limited to, microorganisms. The target nucleic acid molecule may be a nucleic acid molecule that is a nucleic acid fragment of a living organism, such as an organ, a cell, a tissue, an organ, or an organism. Cells that may be used include prokaryotic cells (bacterial cells, e.g., Escherichia coli). a), Bacillus, Serratia, Salmonella (S almonella, Staphylococcus, Streptococcus reptococcus, Clostridium, Chlamydia (Chlamydia), Neisseria, Treponema onema, Mycoplasma, Borrelia ), Legionella, Pseudomonas , Mycobacterium, Helicobacter bacter, Erwinia, Agrobacterium cterium, Rhizobium, and Streptomyces g enera; Crenarchaeota, Nanoarchaeota Archaea such as oarchaeota, or euryarchaeotia or fungal (e.g., yeast), plant, protozoan and other parasites, and animal (insect ( For example, fruit flies (Drosophila spp.), nematodes (e.g. Insects (Caenorhabditis elegans), and mammals (e.g., rats The target cell may be a eukaryotic cell, such as a mammalian cell, mouse, monkey, non-human primate, and human. The nucleic acid and template nucleic acid can be synthesized using a variety of methods well known in the art. Specific sequences can be enriched. Examples of such methods are set forth herein, which are incorporated by reference in their entirety. These and other related techniques are provided in International Publication No. WO 2012 / 108864, which is incorporated herein by reference. In some embodiments, the nucleic acids are further concentrated during the template library preparation method. For example, the nucleic acid may be inserted before the transposome, after the transposome is inserted, and and / or after amplification of the nucleic acid, enrichment for specific sequences may be performed.
[0136] In some embodiments, the target nucleic acid and / or the template nucleic acid are highly purified. For example, nucleic acids can be purified to reduce or eliminate contaminants prior to use in the methods provided herein. Approximately 70%, 80%, 90%, 95%, 96%, 97%, 98%, 99%, or 100% In some embodiments, the present invention may be free of any known art-known It is beneficial to use a method that preserves the quality and size of the target nucleic acid being purified, e.g. DNA isolation and / or direct transposition may be performed using agarose plugs. It can also be performed directly on cells, using cell populations, lysates, and unpurified DNA.
[0137] In some embodiments, the target nucleic acid may be obtained from a biological sample or a patient sample. As used herein, the term "biological sample" or "patient sample" refers to tissue and This includes samples of body fluids, etc. "Body fluids" include, but are not limited to, blood, serum, plasma, etc. , saliva, cerebrospinal fluid, pleural fluid, tears, lactal duct fluid, Examples of samples include lymphocytes, sputum, urine, amniotic fluid, and semen. An "acellular body fluid" contains less than about 1% (weight / weight) total cellular material. Plasma or serum are examples of acellular body fluids. The sample may be of natural or synthetic origin (i.e., acellular). The term may include a specimen of a cell sample (a cell sample prepared to obtain a
[0138] In some embodiments of the methods disclosed above, the target nucleic acid is a target nucleic acid transfected with Flagyl was then depolymerized (e.g., by sonication, restriction digestion, or other mechanical means) prior to exposure to the peptide. It can be mentified.
[0139] As used herein, the term "plasma" refers to the cell-free liquid found in blood. The whole blood is separated by methods known in the art (e.g., centrifugation and filtration, etc.). It may be obtained from blood by removing the cellular material.
[0140] Unless otherwise specified, the terms "a" or "an" are used throughout this specification to mean "one or more means "more than that."
[0141] The terms "for example," "eg," and "such as" has," "include," "including," or When these variations are used herein, these terms are not to be construed as terms of limitation. and means "but is not limited to" or "without being limited to." Then it is interpreted as:
[0142] The following examples are provided for illustrative purposes and in no way constitute any part of the invention provided herein. This does not limit the invention. EXAMPLES
[0143] Example 1 Yield of DNA Clusters from the Bead-Based Tagmentation Process The yield of DNA clusters from the bead-based tagmentation process in Figure 3 was evaluated, and the yield of DNA clusters from the bead-based tagmentation process in Figure 4 was evaluated. In this example, 50 ng, 250 ng, and 1000 ng of human NA128 78 DNA was tagmented using the same batch of tagmentation beads (2.8 μm beads). A second 50 ng aliquot of NA12878 DNA was added to the second batch of tagmentation. Tagmentation was performed using purified beads (perfect repeat: 2.8 μm beads). The tagmented DNA samples were PCR amplified and purified. Aliquots (5.4 μL) of each sample were The PCR product (unquantified) was diluted 270-fold to prepare a stock sample solution of approximately 50 pM. For each sample, the 50 pM stock solution was diluted to 15 pM, 19 pM, 21 pM, and 2 The diluted samples were used for cluster generation and sequencing. The data show that starting with the same dilution (~50 pM), the cluster The number of stars was calculated using three different input levels (i.e., 50n It can be seen that the range is between 100 and 114% for the respective concentrations (250 ng, 1000 ng, and 250 ng). The number of clusters with 50ng perfect repeat (using different batches of beads) was 81%. The different dilutions (15 pM, 19 pM, 21 pM, and 24 pM) showed approximately 10% or greater The data show that beads have a large control over yield and is found to be reproducible with different DNA inputs and different repeats.
[0144] Example 2 Reproducibility of the Bead-Based Tagmentation Process The reproducibility of the bead-based tagmentation process of FIG. 3 is shown in FIG. Six different types of indexed beads (index Preparations were run at 50 ng and 500 ng of input NA1 The tagmented DNA was prepared using 2878 DNA. The 12 purified PCR products were pooled for two HiSeq lanes. The mixture was divided into two mixtures (pool 1 and pool 2) of six samples each. Each pool consisted of one The data table 500 contains samples with 3-50 ng and 3-500 ng per sieve. The median and mean insert sizes of the indexed samples are shown.
[0145] Example 3 Pool 1 Insert Size and Pool 2 Insert Size The insert size of pool 1 and the insert size of pool 2 for the indexed samples in Figure 5 are The data are shown in Figures 6A (plot 600) and 6B (plot 650), respectively. Additionally, the intercalation size was consistent among the six different indexed bead preparations. Bead-based tagmentation is a mechanism for controlling insert size and DNA yield. results.
[0146] Example 4 Reproducibility of total number of reads Reproducibility of total number of reads and percentage of aligned reads for the experiments described in Figure 5 This is shown in Figure 7 (bar graph 700). At both inputs (50 ng and 500 ng), The total number of indexed beads is similar for the same indexed bead preparation. Four of the dexed bead preparations (indexes 1, 2, 3, and 6) were The indexed bead preparations 4 and 5 showed similar yields, whereas the indexed bead preparations 5 and 6 showed similar yields due to the index sequence. There was some variability that may be due to the nature of the
[0147] In one application, the bead-based tagmentation process includes a tagmentation step. Exome enrichment assays, such as Illumina's Nextera® Rapid Rapid capture enrichment protocols may be used. Nextera® Rapid Capture and Concentration Protocol from Mina Tagmentation (Nextera) is used to fragment genomic DNA. Use gene-specific primers to pull down a specific gene fragment of interest After two enrichment cycles, the pulled-down fragments were subjected to PCR and sequencing. Concentrate by slicing.
[0148] To evaluate the use of a bead-based tagmentation step in an exome enrichment assay , Human NA12878 DNA, 25ng, 50ng, 100ng, 150ng, 20 The control group was tagmented using 0 ng and 500 ng of input DNA. The library (NA00536) was purified using 50 ng of input DNA according to standard protocols. A. Each DNA input had a different index (unique identifier). To comply with standard methods and ensure sufficient fragments are present for pulldown To ensure the Ten cycles of PCR were performed using the PCR polymerase mastermix. The amplification protocol consisted of 3 min at 72°C, 30 s at 98°C, followed by 10 cycles of 10 s at 98°C. The incubation times were: 1 min at 65°C, 30 s at 65°C, and 1 min at 72°C. The samples were then held at 10°C. The samples were then processed through an exome enrichment pull-down process and sequencing. Ta.
[0149] Example 5. Control library and bead-based exome enrichment assays Insert size of tagmented libraries 8A, 8B, and 8C show the control exome enrichment assays, respectively. Plot of insert size in 800 bead-based tagmented libraries A plot 820 of insert size across the 1000 bp region and a summary data table 840 are shown. For example, bead-based tagmented libraries showed broader cloning than control libraries. Although the insert size distribution is fairly uniform, the insert sizes are very similar regardless of the DNA input of the sample. You can see how close they are.
[0150] Example 6. Quality of lead sequences 9A, 9B, and 9C are the exome-enriched versions of FIGS. 8A, 8B, and 8C, respectively. PF: duplicates that passed the filter Bar graph of the proportion of passing filters in 900, PCT selected Bar graph of bases 920 and PCT usable bases on tar 9A shows a bar graph 940 of the get. Referring to FIG. 9A, the percentage of dups PF is This is a measure of how many reads are replicated in other parts of the flow cell. To ensure that all clusters contribute useful data to the results, , ideally it would be low (as shown here).
[0151] Figure 9B shows the PCT selected bases, which were enriched during the enrichment step. It is a measure of the proportion of reads that sequence at or near the site of interest that should have been present. This number will be close to 1, reflecting the success of the concentration process. This indicates that leads that should not be enriched did not complete the process.
[0152] Figure 9C shows the PCR usable bases on target. It is a measure of the proportion of reads that actually align to a particular base of interest within a given region. Ideally, all enriched reads should align to the desired base within the enriched read. However, due to the random nature of tagmentation and the variable length of insertions, Unaligned reads may be enriched.
[0153] Two techniques may be used to optimize the insert size distribution. Cleanup may be used to remove fragments that are too small or too large. RI cleanup determines the size and retention of the desired precipitated or unprecipitated DNA (i.e., the first step). The triplicate precipitates only DNA larger than the desired size, leaving small soluble fragments. Selective DNA precipitation based on the size of the fragments (i.e., the fragments that are larger or smaller than the desired size) can be performed. The next step is to remove the small fragments. At this time, the unwanted very small fragments (still in solution) are removed and the precipitated DNA is The DNA is then retained, washed, and resolubilized to obtain DNA of the desired size range. For example, the spacing of activated transposomes on the bead surface can be used to determine the insert size distribution. For example, gaps on the bead surface may be filled with inactive transposomes (e.g., Alternatively, the vector may be filled with a transposome carrying an inactive transposon.
[0154] The continuity of the bead-based tagmentation process was evaluated. Table 3 shows the continuity of the bead-based tagmentation process. The number of times that a read occurred 0, 1, 2, or 3 times within a 1000 bp window. The beads were generated with nine different indexed transposomes to capture small amounts of human DNA. A was used to tagment A. Reads were generated, aligned, and all reads that shared the same index were The number of reads within a 1000 bp or 10 Kb window was analyzed. Some of the reads within a small window that share the same sequence may be generated by chance. The predictions for how many times this is likely to occur are shown in the "Random" column of Tables 3 and 4. The number of "beads" in the string shares an index of 1000bp (Table 3) or 10Kp (Table 4). The actual number of windows is shown in Tables 3 and 4. As shown in Tables 3 and 4, the same index is 1000. The actual number of times found within a bp or 10Kp window is greater than expected in a random case. The "0" frame is the interval in which a particular 1000bp window maps to it. The numbers show all times that only a small amount of the human genome was sequenced. This is because most windows are sequenced and do not have reads aligned to them. "1" is the largest number in this case. Only one read has a 1000bp (or 10Kp) win. The number of times to map to the doe is "2" within a 1000bp (or 10Kp) window. The number of times two reads share an index, etc. This data is In more than 10 cases, the same piece of DNA (>10Kp) is tagged approximately 15,000 times. Within a tagmentation event, the same bead was tagmented at least two to five times. This suggests that fragments are not evenly spaced because they share indexes. It is unlikely that they would have been there naturally and come from the same bead.
[0155] [Table 3]
[0156] Table 4 shows the number of reads (up to 5) within a 10Kp window that shares an index. .
[0157] [Table 4]
[0158] Example 7 Separation of free transposomes from CPT-DNA After transposition, the reaction mixture containing CPT-DNA and free transposomes was incubated with Sepha Cryl S-400 and Sephacryl S-200 size exclusion chromatography The CPT-DNA was subjected to column chromatography using NC It is labeled P DNA.
[0159] Example 8 Optimization of Capture Probe Density on Beads The density of capture probes A7 and B7 was optimized on 1 μm beads and the results are shown in FIG. Lanes 1 (A7) and 3 (B7) have high probe density, while lane 2 (A 7) and lane 4 (B7) show an estimated 10,000 to 100,000 per 1 um bead. The ligation product of the capture probe to the target molecule was agarose gel electrophoresis. The probe densities of approximately 10,000 to 100,000 per bead were evaluated in gels. Higher probe densities had better ligation efficiency.
[0160] Example 9 Indexing of CPT-DNA on Beads by Intramolecular Hybridization Feasibility study of preparation of cross-linked sequencing libraries The transposomes were then ligated to the A7' and B7' capture sequences, which are complementary to the A7 and B7 capture sequences on the beads. By mixing transposons carrying capture sequences with hyperactive Tn5 transposase, High molecular weight genomic DNA was mixed with transposomes, and CPT-DNA was added. Separately, beads are prepared by immobilizing the following oligonucleotides: P5-A7, P7-B 7, or P5-A7+P7-B7, where P5 and P7 are primer binding sites. A7 and B7 are capture sequences complementary to the A7' and B7' sequences, respectively. P5-A7 alone, P7-B7 alone, P5-A7 + P7-B7, or P5-A7 beads and The beads, including the mixture of P7-B7 beads, were treated with CPT-DNA and added to the reaction mixture. Add gauze to check the efficiency of hybridization of the immobilized oligo to the transposition DNA. The results are shown in Figure 26. The sequencing library was As indicated by the high molecular weight band, both P5-A7 and P7-B7 were bound to a single bead. The results show that the ELISA was generated only when the antibody was immobilized on the surface of the antibody (lane 3). hybridization and intramolecular hybridization on beads. We demonstrated the feasibility of preparing an indexed sequencing library of PT-DNA. Ta.
[0161] Example 10. Feasibility study of clone indexing Several sets of transposomes were prepared. In one set, the hyperactive T n5 transposase was mixed with the transposon sequence Tnp1, which has a 5' biotin. Prepare transposome 1. In another set, prepare a unique indicator with 5' biotin. In another set, transposome 2 is prepared with Tnp2 carrying transposome 2. For the preparation of transposome 3, hyperactive Tn5 transposase was transfected with 5' biotin. In another set, the transposon sequence Tnp3 is mixed with the unique index Prepare transposome 4 with Tnp4 carrying 4 and 5' biotin. Transposomes 1 and 2, and transposomes 3 and 4 were each separately incubated with streptavidin. The beads are mixed with the beads to produce beads set 1 and beads set 2. The two sets of beads are then The mixture was mixed and incubated with genomic DNA and tagmentation buffer. Promotes tagmentation of genomic DNA, followed by PCR amplification of the tagmented sequences The amplified DNA is sequenced and the insertion of the index sequence is analyzed. When ligation is confined to the beads, the majority of fragments are Tnp1 / Tnp2 and Tnp3. p3 / Tnp4 index. Intramolecular hybridization If there is, the fragments are Tnp1 / Tnp4, Tnp2 / Tnp3, Tnp1 / Tnp3 and Tnp2 / Tnp4 indexes. The sequencing results after 10 cycles of PCR and 10 cycles of PCR are shown in Figure 27. has all four transposons mixed and immobilized on beads. The results are , the majority of sequences have Tnp1 / Tnp2 or Tnp3 / Tnp4 indexes This indicates that clone indexing is feasible. Indicates that the index is insensitive.
[0162] Example 11 Indexed clonal bead transposition in a single reaction Prepare 96 indexed transposome beads. Individual indexes The transposome contains a Tn5 mosaic end sequence (ME) at the 5' end and an index The transposons containing the oligonucleotides with the sequences were mixed and prepared. The indexed transposomes are then bound to beads via streptavidin-biotin interaction. The transposomes on the beads were washed, and all 96 individual transposomes on the beads were The individually indexed transposomes were pooled. An oligonucleotide having a specific nucleotide sequence is annealed to the immobilized oligonucleotide. We created a transposon with 96 different indexed clones. Mix the transposome beads set and incubate them in high molecular weight (HMW) solution. cular weight) genomic DNA along with the Nextera tagmented buffer. The cells were incubated in a single tube in the presence of
[0163] The beads were washed and the transposons were isolated by treating the reaction mixture with 0.1% SDS. The tagmented DNA is amplified with indexed primers and purified using PEHi Sequencing with TrueSeq v3 Cluster Kit on Seq Flow Cell v2 The sequencing data are analyzed.
[0164] Observe clusters of reads, or islands. The plot shows two main peaks, one from within the cluster (proximal) and one from within the cluster (class The schematic diagram of the method and results is shown in Figures 30 and 31. The size of the islands ranges from about 3 to 10 kb. The percentage of bases covered is about 5. The insertion size of genomic DNA is approximately 200 to 300 bases.
[0165] Example 12 Library size for transposomes on beads First, a first oligonucleotide having the ME' sequence, ME-barcode-P5 / P Mixing the second oligonucleotide having the sequence 7 and the Tn5 transposase In the first set, the transposomes were assembled in solution by The first oligonucleotide carrying the sequence is biotinylated at the 3' end. The oligonucleotide having the ME-barcode-P5 / P7 sequence was attached to the 5' end of the Various concentrations (10 nM, 50 nM, and 200 nM) of each of the resulting transactivities were Streptavidin beads were added to the transposome set to confirm that the transposomes were The beads were washed and the HMW genomic DNA was then immobilized on streptavidin beads. Add A and perform tagmentation. In some cases, add 0.1% of the tagmented DNA. In other cases, tagmented DNA is not treated with SDS. A is PCR amplified for 5 to 8 cycles and sequenced. A schematic diagram is shown in Figure 32.
[0166] As shown in Figure 33, SDS treatment improved the amplification efficiency and sequencing quality. Oligonucleotides with 3' biotin have better labeling properties for transposomes. It has a library size.
[0167] Figure 34 shows the effect of transposome surface density on insert size. Transposomes with smaller library sizes and more self-inserts Shows by-products.
[0168] Example 13 Titration of Input DNA Various amounts of target HMW DNA were cultured in a clone with a Tn5:transposon density of 50 mM. Add to Lawn Index beads and incubate at 37°C for 15 or 60 minutes or at room temperature. The transposomes were incubated for 60 minutes. The reaction mixture was treated with 0.1% SDS and PCR amplification was performed. The amplified DNA was sequenced. Figure 35 shows the intensity distribution of the size distribution. The effect of 10 pg of input DNA on the reaction yielded the minimum signal. The size distribution patterns were similar for DNA inputs of 20 pg, 40 pg, and 200 pg. The same was true for
[0169] Example 14 Islet size and distribution using solution-based and bead-based methods The size and distribution of islets were compared using solution-based and bead-based methods. In this approach, 96 species with unique indices for each transposon were identified. Assemble the transposomes in a 96-well plate. Add HMW genomic DNA. The reaction product is treated with 0.1% SDS and amplified by PCR. The amplified DNA was sequenced.
[0170] In the bead-based approach, each transposon has a unique index. Ninety-six different transposomes were assembled in a 96-well plate. The streptavidin beads contained 3'-end biotin. Add 100 µL of ... The beads are washed and pooled, HMW genomic DNA is added, and tagmentation is performed. The homogenization reaction is carried out in a single reaction vessel (one-pot). The reaction product is treated with 0.1% SDS. The PCR products were amplified and sequenced.
[0171] For the negative control, we first used 96 different types of IgG, each with a unique index. All transposon sequences are mixed. The oligonucleotides contain a 3'-end biotin. Transposomes are prepared from individual mixed-indexed transposons. Add leptoavidin beads to the mixture. Add HMW genomic DNA and tagment it. The reaction product is treated with 0.1% SDS and amplified by PCR. Quenched.
[0172] The number of intraislet reads is plotted against the size of the islet. The results shown in Figure 36 show that the number of intraislet reads is significantly higher in the islet (proximal link) ) observed with one-pot clone-indexed beads as well as solution-based methods. The indexed transposon was inserted prior to transposome formation. When mixed, no islands (proximal leads) were observed. By mixing transposomes, different indexes / transposomes can be obtained per bead. That is, non-clonal beads are obtained.
[0173] Example 15 Analysis of structural variations using CPT-seq Detection of 60 kb heterozygous deletion Extract the sequencing data as fastq files and separate (demultiplex) A CPT analysis step is performed to generate individual fastq files for each barcode. Fastq files from sequencing runs are separated according to index and duplicates are removed. The index represents any read within the scan window. Chromosomes are scanned with 5kb / 1kb windows, recording the number of chromosomes. In the heterozygous deletion region, only half the amount of DNA was included in the library compared to the adjacent region. Therefore, the number of indexes should also be approximately half the number of adjacent regions. NA12878 60kb heterozygous deletion in chr1, 9216 indexed By scanning a 5 kb window from the CPT sequencing data, Fig. 47 A and 47B.
[0174] Gene fusion detection Fastq files from CPT sequencing were separated according to index, Align to the reference genome with duplicates removed. Scan chromosomes in 2 kb windows. Each 2 kb window is 36864 vectors, and reads from unique indices are Each element records how many of the elements it finds in a 2 kb window across the genome. For each 2kb window pair (X, Y), we use weighted Jaccard. ccard) index of the sample. This index is effectively the (X, Y). These indices are displayed as a heat map as shown in Figure 48. Each data point represents a pair of 2 kb scan windows, and the top left box represents The lower right corner is X and Y from area 1, the lower right corner is X and Y from area 2, and the upper right corner is X and Y from area 3. The gene fusion signal is X, Y from the region spanning region 1 to region 2 in this case. is shown as the horizontal line in the middle.
[0175] Detection of defects Fastq files from CPT sequencing were separated according to index, Align to the reference genome with duplicates removed. Scan chromosomes in 1 kb windows. FIG. 49 shows the results of detection of gene deletion.
[0176] Example 16 Phasing and methylation detection Optimizing bisulfite conversion efficiency The indexed bound CPT-seq library on the beads was subjected to ME (Mosaic Epitaxy) Conversion was evaluated in the chromosome (chromosome region) and gDNA region. The ylEdge bisulfite conversion system was optimized to improve efficiency.
[0177] [Table 5]
[0178] The ME sequences were analyzed to determine the efficiency of the bisulfite conversion treatment and are shown in Figure 50. Of the indexed binding libraries attached to the BS, 95% were bisulfite converted (BS C). Similar PCR yields were observed between the bisulfite conditions. Hydrogen salt treatment did not appear to degrade the library. BSC was observed in approximately 95% of the indexed binding libraries. The variables studied to determine the denaturation were temperature and NaOH concentration (denaturation). 1M NaOH, or °C and 0.3M NaOH gave good results.
[0179] After sequencing the BSC-converted CPT-seq bead library, the expected sequence was The sequencing read structure was observed. The percentage of bases was measured using the IVC plot. This is also shown in Figure 52.
[0180] Figure 53 shows the results of the indexed combined library after PCR following bisulfite conversion. The image of agarose gel electrophoresis is shown. The expected size range of 200-500 bp was observed. In the reaction without DNA, the indexed ligated library Not produced.
[0181] Example 17 Target Phasing Enrichment of the whole genome indexed combined CPT-seq library. Pre-enriched whole-genome indexed combined CPT-seq libraries without size selection Figure 55 shows an agarose gel of the library after enrichment. The analysis is presented.
[0182] The enrichment statistics for the HLA regions are shown below.
[0183] [Table 6]
[0184] FIG. 56 shows the results of applying targeted haplotyping to the HLA regions of chromosomes. A schematic of the enrichment of a whole genome indexed combined read library is shown on the left. Each represents a short indexed library. The raster is a cloned indexed region with the same index on a single bead. These are "islands" of genome-wide sequence information, and therefore indicate the proximity of reads on a genome-wide scale. Enrichment of libraries in target regions (WO 2012 / 108864 "Selection of nucleic acids") Selective enrichment of nucleic acid The reads are enriched in the HLA region. When the reads are sorted by index and aligned to the genome, the reads are The “island” structure is again shown, indicating that continuity information is maintained from the input.
[0185] Example 18: Index exchange To evaluate the exchange of mosaic ends (MEs) in transpososome complexes, we used different indole-1-phosphate dehydrogenase (1-phosphate dehydrogenase) ... After mixing, the library was sequenced and each library was The decision was made to exchange the index by reporting the index of the branch. The percentage of "swapped" is (D4+D5+E3+E5+f4) / (total 96 The calculation was done using the total number of species (sum of all species).
[0186] Example 19. Crowding of transposome complexes with streptavidin beads Reducing library insert size by Streptavidin magnetic beads were loaded with 1x, 6x, and 12x concentrations of TsTn5 transactivator. For each bead type, the Epi-CPTSeq probe was The final PCR products were then purified using the Agilent BioAnalyzer for analysis. The Epi-CPTSeq library fragments were loaded onto a 30-well plate as shown in the figure. It was relatively small and was produced in greater amounts the more TsTn5 was loaded onto the beads.
[0187] Example 20 Fragmentation of DNA libraries during bisulfite conversion After bisulfite conversion, DNA is damaged, resulting in the deletion of the consensus sequence ( CS2) is decreased. DNA fragments CPTSeq and Epi-CPTSeq (Me The libraries were analyzed using a BioAnalyzer. Due to DNA damage during translation, the Epi-CPTSeq library was Five-fold lower yield and smaller library size compared to CPTSeq libraries It has a distribution.
[0188] Example 21 TdT-mediated ssDNA ligation reaction DNA end repair by terminal deoxyribonuclease (TdT)-mediated ligation The feasibility was tested. Briefly, 5 pmol of ssDNA template was incubated with TdT (10 / 50 U) , attenuator / adaptor duplex (0 / 15 / 25 pmol), and DNA liger The mixture was incubated with 0 / 10 U of ribosomal enzyme at 37°C for 15 min. The DNA products of the reactions were analyzed on a TBE-Urea gel and the results are shown in Figure 71. Addition of the components resulted in nearly complete ligation of the adapter molecule (lane 5). ~8).
[0189] DNA end repair by terminal deoxyribonuclease (TdT)-mediated ligation The feasibility was tested against the sodium bisulfite converted bead-bound library. Briefly, DNA was tagmented on beads (first two lanes) and then purified using Promec. GA's MethylEdge Bisulfite Conversion Kit (lanes 3 and 4), D The NA rescue protocol was performed (lanes 5 and 6). Yield of DNA library after rescue reaction The amount and size of the chromosomes are clearly increased. The abundance of insertion transposons (SIs) is also increased. , indicating efficient ligation of the adapter molecule.
[0190] The results of the methyl-CPTSeq assay are shown in FIG.
Claims
1. (a) contacting a target nucleic acid with a plurality of transposome complexes, Each transposome complex comprises a transposon and a transposase, the transposon comprises a transferred strand and a non-transferred strand, and at least one of the transposons of the transposome complex comprises an adapter sequence capable of hybridizing to a complementary capture sequence; (b) fragmenting the target nucleic acid into multiple fragments and inserting multiple transferred strands with the transposome complex, wherein adjacent fragments are linked to each other via the transposome complex and contiguity of the fragments of the target nucleic acid is maintained by the transposase; (c) contacting the linked fragments of the target nucleic acid with a plurality of solid supports, each of the plurality of solid supports comprising a plurality of immobilized oligonucleotides, each of the immobilized oligonucleotides comprising a complementary capture sequence and a first barcode sequence, wherein the first barcode sequence from each solid support in the plurality of solid supports is different from the first barcode sequences from other solid supports in the plurality of solid supports; (d) transferring the barcode sequence information to the linked fragments of the target nucleic acid, wherein at least two fragments of the same target nucleic acid receive identical barcode information; (e) subjecting said fragments of the target nucleic acid containing the barcode to a bisulfite treatment, thereby generating bisulfite-treated target nucleic acid fragments containing the barcode; (f) determining the sequences of the bisulfite-treated target nucleic acid fragments and the barcode sequences; (g) determining contiguity information of the target nucleic acid by identifying the barcode sequence; The sequence information indicates a methylation state of the target nucleic acid, and the sequence information indicates haplotype information. A method for simultaneously determining the phasing information and methylation status of a target nucleic acid sequence.
2. The method of claim 1, wherein a single barcode sequence is present on the multiple immobilized oligonucleotides on each individual solid support.
3. The method described in claim 1 or 2, wherein different barcode sequences are present on the multiple immobilized oligonucleotides on each individual solid support.
4. A method according to any one of claims 1 to 3, wherein the transfer of the barcode sequence information to the target nucleic acid fragment is performed by ligation.
5. The method of claim 1, wherein the barcode sequence information is transferred to the target nucleic acid fragment by polymerase extension.
6. A method according to any one of claims 1 to 4, wherein the transfer of the barcode sequence information to the target nucleic acid fragment is performed by both ligation and polymerase extension.
7. The method of claim 5 or 6, wherein the polymerase extension is performed by using the ligated immobilized oligonucleotide as a template and extending the 3' end of the unligated transposon strand with a DNA polymerase.
8. The method of claim 1, wherein at least a portion of the adapter sequence further comprises a second barcode sequence.
9. A method described in any one of claims 1 to 8, wherein the transposome complex is a multimer and the adapter sequence of the transposon of each monomer unit is different from other monomer units of the same transposome complex.
10. The method of claim 1, wherein the adapter sequence further comprises a first primer binding sequence.
11. The method of claim 10, wherein the first primer binding site has no sequence homology to the capture sequence or the complement of the capture sequence.
12. The method of claim 1, wherein the immobilized oligonucleotide on the solid support further comprises a second primer binding sequence.
13. The method of claim 1, wherein the transposome complex is a multimer and the monomer units of the transposome are linked to each other within the same transposome complex.
14. The method described in claim 13, wherein a transposase of a transpososome monomer unit is bound to another transposase of another transpososome monomer unit of the same transposome complex.
15. The method of claim 14, wherein a transposon of a transposome monomer unit is bound to a transposon of another transposome monomer unit of the same transposome complex.
16. A method described in any one of claims 1 to 15, wherein the continuity information of the target nucleic acid sequence indicates haplotype information.
17. A method according to any one of claims 1 to 15, wherein the continuity information of the target nucleic acid sequence indicates a genomic mutation.
18. The method described in claim 17, wherein the genomic mutation is selected from the group consisting of deletions, rearrangements, interchromosomal gene fusions, duplications, and paralogs.
19. The method of claim 1, wherein the oligonucleotide immobilized on the solid support comprises a partial double-stranded region and a partial single-stranded region.
20. The method of claim 19, wherein the partially single-stranded region of the oligonucleotide comprises the second barcode sequence and the second primer binding sequence.
21. A method according to any one of claims 1 to 20, wherein a target nucleic acid fragment containing the barcode is amplified prior to determining the sequence of the target nucleic acid fragment.
22. The method of claim 21, wherein steps (a) to (d) and the subsequent amplification are carried out in a single reaction compartment prior to determining the sequence of the target nucleic acid fragment.
23. The method of claim 21, wherein a third barcode sequence is inserted into the target nucleic acid fragment during the amplification.
24. A method for producing a method of producing a barcode-containing target nucleic acid fragment of step (d) from a first set of reaction compartments into a pool of barcode-containing target nucleic acid fragments; redistributing the pool of target nucleic acid fragments comprising the barcodes into a second set of reaction compartments; amplifying said target nucleic acid fragments in said second set of reaction compartments prior to sequencing, thereby introducing a third barcode into said target nucleic acid fragments; The method of any one of claims 1 to 23, further comprising:
25. The method of claim 1, further comprising the step of prefragmenting the target nucleic acid prior to contacting the target nucleic acid with a transposome complex.
26. The method of claim 25, wherein the step of prefragmenting the target nucleic acid is carried out by a method selected from the group consisting of sonication and restriction digestion.
